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 In many cases, the last event that precipitates myocardial infarction is total 
occlusion of a coronary artery due to acute thrombotic occlusion.  High shear rates due to 
stenosis in the arteries are a dominant cause of the thrombotic reaction.  Studies of 
thrombosis under arterial stenotic flow conditions have shown that the rate of platelet 
deposition increases under increasing shear rate and may or may not occlude the vessel.  
A thrombosis model that leads to complete occlusion in vitro reproducibly has been 
developed in this work with recording of video, flow, and histology.  This model includes 
porcine whole blood anticoagulated with heparin and flowed through glass stenoses 
coated with collagen Type I.  Visualization of thrombus formation in this model 
illustrates how platelets adhere to stenoses, form thrombus in concentric striations in the 
throat, and completely occlude at the throat of stenosis causing flow cessation. 
 Poiseuille flow in the stenosis region estimates that shear rates were initially 
between 10,000/s and 40,000/s.  Platelet deposition has been quantified using optical and 
flow modeling throughout the experiment and both methods show reasonable 
concordance with similar studies.  The rate of platelet deposition has been shown to 
increase with shear rates as high as 40,900/s.  The adhesive strength of a platelet on the 
periphery of the thrombus has also been measured by removing a completely occlusive 






 In 2002, 696,947 deaths in the United States occurred due to diseases of the heart, 
which is 28% of the total deaths [1].  Cardiovascular disease has consistently been the 
leading cause of natural death in developed nations, of which, 50% are estimated to be 
caused by sudden death from cardiac causes [2].  80% of these sudden deaths are caused 
by acute ventrical tachyarrhythmias often triggered by acute coronary events [2].  The 
surprising feature of these occurrences is that they may occur in persons without previous 
cardiac symptoms.  Most cases of sudden death occur in larger, lower-risk subgroups 
such as patients with high coronary risk as opposed to patients with previous myocardial 
infarction [3].  It is the unexpected nature of sudden cardiac death (SCD) that makes the 
predictions of acute coronary events so important. 
SCD has been shown to link to acute myocardial infarction caused by coronary 
thrombosis or to an arrhythmia arising within a scarred left ventricle [4].  Of 168 cases of 
sudden ischemic death, a ratio of 2.7:1 cases showed coronary thrombosis [4].  Therefore, 
an important precipitating event in many cases of sudden death is mural thrombosis that 
occludes the lumen and restricts blood flow distally.  When blood flow is reduced to the 
heart muscle a low oxygen state referred to as ischemia exists and without return of blood 
flow, will lead to irreversible infarct in the myocardium.  Tissue that is ischemic does not 
conduct the electrical signals that produce contractions in the heart ventricles, leading to 
an arrhythmia which causes heart arrest and ultimately death.   
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One of the most clinically significant problems of thrombosis is when a thrombus 
forms superimposed on ruptured atherosclerotic plaque, sometimes referred to as 
atherothrombosis [5].   This term describes the combination of both the acute and chronic 
events in arterial disease [6].  In the heart, acute thrombosis leads to most cases of 
unstable angina or myocardial infarction through the embolization of thrombi or the 
formation of occlusive thrombus.  Thrombus formation in stenotic arteries is largely 
dependent on platelet function and the goal of this research is to gain new understanding 
of the ability of platelets to aggregate under high shear conditions in regions of stenosis.   
In coronary artery disease (CAD), the vessel progressively becomes narrowed by 
the enlargement of a plaque, called an atheroma, in the intimal layer.  The atheroma 
consists of smooth muscle cells, lipids, collagen, elastin, and sometimes calcium deposits.  
The constriction caused by the atheroma is clinically referred to as a stenosis [7].  A 
stenosis is typically defined by the diameter reduction, as in Equation 1, where D1 is the 








DDStenosis   Equation 1 
 
There are very high velocities at the stenosis throat and one effect is that there is 
low pressure at the stenosis throat according to Bernoulli’s law.  This low pressure may 
in extreme cases be lower than the external pressure [7, 8].  As a result, local collapse in 
the artery leading to choked flow or in combination with pulsatile flow can cause 
oscillating compressive stress on the plaque cap [9].  The cyclical compressive stress can 
lead to fracture fatigue in the surface of the plaque [10, 11].   
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Thrombus formation is initiated when an atherosclerotic plaque cracks or fissures.  
In a study of 90 patients that died of ischemic heart disease within six hours of onset 
symptoms, Davies found plaque fissures in 86, and of these 31 (36%) had thrombus that 
occluded the artery [12].  He also found intravascular masses of platelets in 27 of the 90 
which he thought represented an embolic phenomenon and potential cause of unstable 
angina.  Therefore, atherothrombosis may block at the rupture site or dislodge and block 
flow in smaller vessels downstream.  Figure 1 shows an example of a ruptured plaque 
with mural thrombus. 
 
 
Figure 1.  Atherothrombosis is commonly found in autopsy studies of heart disease. [13].  
The lipid core has been filled with thrombus but does not occlude the lumen. 
 
Pathologists Davies and Falk independently studied coronary lesions that 
produced unstable angina and myocardial infarction.  Both studies concluded that platelet 
masses are only found downstream of plaques where thrombus has developed [12].  
Therefore unstable angina has been linked to embolism from coronary atherothrombosis.  
Although typically more than one coronary artery has plaques present, on autopsy, it is 
found that most deaths occur because of the thrombotic occlusion of a single plaque [14].   
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Falk introduced a concept of ‘dynamic’ thrombosis where the degree of flow 
obstruction caused by the stenosis varies due to (1) focal vasospasm, and (2) transient 
platelet aggregation at the site of a severe atherosclerotic stenosis.  In 14 out of 15 
patients examined during autopsy, he concluded that the period of unstable angina before 
the final heart attack was characterized by an ongoing thrombotic process where recurrent 
mural thrombus formation was followed by thrombus fragmentation [15].  Therefore 
stenosis severity may increase with increased plaque deposits or through repeated mural 
deposits of thrombus.   
Coronary plaque rupture is dependent on the composition and vulnerability of the 
atheroma.  Thrombosis due to plaque disruption is usually seen in plaques with lower 
degrees of initial stenosis which may not be visible by angiography [16].  Vulnerable 
plaques are typically soft and have a large core of extracellular lipid, densely 
accumulated macrophages, and reduced numbers of smooth muscle cells which is 
covered by a thin cap [17].  Angiographic studies early on demonstrated that nearly two-
thirds of all myocardial infarction (MI) originate at atherosclerotic lesions that lack 
hemodynamic significance [14].  The hemodyamic significance of a lesion is determined 
by the reduction in cross-sectional area of the stenosis which contributes to the pressure 
loss [18].  Therefore vulnerable plaques may have initially low percent stenosis yet lead 
to clinical symptoms.   
 So how long does thrombotic occlusion take in vivo?  In a study of 100 subjects 
who died of ischemic heart disease in less than six hours, Davies categorized the time 
between onset of symptoms and death with the presence of a thrombus in the coronary 
artery.  He found that 20 died within the first 15 minutes, 65% of which had a thrombus, 
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and 39 died between 15 and 60 minutes, 77% of which had a coronary thrombus [19].  20 
of the subjects were found dead and the time span was unknown, and 85% of those had 
coronary thrombus.  Sudden death is typically defined as within the first hour, although it 
is clear that thrombotic occlusion may occur rapidly within 15 minutes. 
Whereas SCD may occur within the general population to persons without 
diagnosed cardiac disease, survival is dependent on immediate attention.  The American 
Heart Association has introduced a ‘chain of survival’ to rescue people suffering from 
cardiac arrest.  The four step process includes early access to medical care, early CPR, 
early defibrillation, and early advanced care [20].  Defibrillation has been shown to help 
the electrical heart arrest, but requires either an implantable device or early response with 
external defibrillation.  The matter of the preceding heart attack may still have 
preventative measures based on inhibiting vulnerable plaques or thrombotic occlusion. 
To summarize, the events preceding cessation of flow include plaque cap fatigue, 
plaque rupture and occlusive thrombosis.  Mural thrombus formation may lead to 
unstable angina or may become occlusive and lead to myocardial infarction.  In instances 
where thrombus formation leads to complete occlusion in a short time span, the patient 
has less opportunity to be rescued by the ‘chain of survival.’  Therefore understanding 
thrombus formation to complete occlusion and tailoring therapies to prevent it are 
valuable solutions to this persistent problem.   
 
Hemostasis and Thrombosis 
 Thrombosis is a pathological consequence of the normal hemostatic process 
which leads to formation of a thrombus in diseased vessels that obstructs flow.  In the 
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chain reaction of hemostasis, bleeding is arrested to prevent the loss of blood through the 
walls of damaged vessels.  Hemostasis can be looked at in three phases.  First, the 
vascular phase is triggered by a cut in the blood vessel wall and leads to smooth muscle 
contraction which reduces the diameter of the vessel at the site of injury.  Next, the 
platelet phase begins when platelets attach to the site of injury and become activated due 
to the release of chemical factors and local hormones by endothelial cells such as 
adenosine diphosphate (ADP) and tissue factor.  The third phase of hemostasis is the 
coagulation phase which begins 30 seconds or more after the vessel wall is damaged and 
the first two phases are initiated.  Coagulation leads to a blood clot reinforced with a 
fibrin mesh which seals off the damaged vessel wall.  This phase is promoted by thirteen 
procoagulant factors and their proenzymes but is also inhibited by anticoagulants such as 
antithrombin-III, heparin, thrombomodulin, prostacyclin and other plasma proteins [21].  
Both the second and third phases of hemostasis are regulated by agonists and inhibitors 
using a positive feedback loop. 
The key player of hemostasis in arteries is the platelet.  Platelets are flattened 
discs that are about 4 µm in diameter and 1 µm thick.  In humans, platelets are generated 
from megakaryocytes in blood marrow that shed cytoplasm in small membrane-enclosed 
packets [21].  These anucleated packets are cell fragments rather than cells and have a 
lifetime of 7-10 days before they are removed by macrophages in the liver or spleen.  
They circulate the vascular system and discriminate between areas of vascular lesion and 
normal endothelium [6], which may be the only nonthrombogenic surface.  Platelets 
respond to the lesion with three functions with some interplay: adhesion, activation, and 
aggregation.   
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 Adhesion of platelets occurs on the subendothelium and the atheroma contents 
using platelet surface receptors, called glycoproteins.  The damaged vessel wall is 
initially covered in a thin monolayer of platelets.  Platelets in this stage bind to von 
Willebrand Factor (vWF) which is a multimeric glycoprotein that acts as a bridge 
between platelets and subendothelial collagens [22].  Under high shear rates, vWF 
circulating in the blood system or produced from endothelial cells is required to adsorb 
on collagen before the initial tethering by platelets by glycoprotein GPIbα can occur [23, 
24].  After the tethering, secondary platelet glycoprotein, such as GPIa/IIa and GPIIb/IIIa 
mediate a more permanent binding [23, 25].  The interaction between platelet GPIbα and 
vWF is discussed further in the next section about the adhesive strength of glycoproteins.   
 In the vessel wall, there are many different types of collagen which are extremely 
reactive with platelets, most notably type I, III, IV, V, and VI [26].  Platelets adhere to 
collagen via integrin-α2β1 (GPIa/IIa) and GPVI [6].  The surface density of GPIa/IIa has 
been estimated to be approximately 1000-2000 copies/cell [27, 28].    
 Platelets become activated by the chemical agonists such as Thromboxane A2, 
thrombin, collagen, platelet activating factor (PAF), and ADP or by shear stresses in the 
presence of vWF, ADP and Ca2+ [29].  After activation, platelets change into a spherical 
shape with cytoplasmic processes, called pseudopods that extend towards other platelets 
and then platelets begin synthesizing and releasing more ADP, Thromboxane A2, platelet 
factors, serotonin, and Ca2+ that promote platelet aggregation [21].  Another important 
process that is triggered by activation is a conformational change in GPIIb/IIIa that 
allows it to bind to plasma proteins [9].  The process of vWF binding to the GPIb-IX-V 
complex is also dependent on conformational changes in one or both of the proteins [30].  
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The GPIb-IX-V complex has four subunits including GPIbα, GPIbβ, GPV, and GPIX 
[31].  The GPIbα subunit contains the binding site for vWF although GPIbβ and GPIX 
are also required to interact with vWF [32].   
Aggregation refers to the accumulation of platelets which is necessary for 
formation of a platelet plug.  Under low to moderate shear rates, it may occur with 
platelet binding using fibrinogen as a bridge or with fibrin (after fibrinogen has been 
cleaved by thrombin) and GPIIb/IIIa [9].  And in high shear regimes, it has been shown 
that aggregation requires the binding of ligands including vWF via its RGD binding 
domain to GPIIb-IIIa [33]. 
The relative proportion of blood cells in a thrombus is dependent on 
hemodynamic factors.  Under low shear, venous thrombosis tends to have red clot 
consisting of red blood cells, platelets, and fibrin mesh.  The difference with arterial 
thrombosis is that the high shear conditions lead to a more densely packed platelet and 
fibrin mesh, called a white thrombus.  The occasional red blood cell may be trapped in a 
white thrombus, but it is primarily composed of platelets and fibrin.  The relative 
proportion of each species may be evaluated from histology or from cell markers used 
during experimentation. 
 Although they dominate thrombus formation, vWF and fibrinogen may not be the 
only necessary ligands in this process.  Mice deficient in both vWF and fibrinogen were 
able to form completely occlusive thrombi in arterioles in vivo which was attributed to 
accumulated fibronectin in the platelet α–granules [34].  Other plasma proteins that 
support the adhesion of platelets such as fibronectin, thrombospondin, and vitronectin are 
heavily researched but do not seem to be as dominant ligands as vWF and fibrin(ogen). 
8 
  
 The vulnerable plaque and the blood constituents are two key elements in the 
pathology of thrombosis.  A third element, in what is called Virchow’s triad, is the 
hemodynamics that contributes to thrombotic occlusion and cardiac diseases.  This 
component will be studied in this work. 
 
Hemodynamics of Stenoses 
 High velocities in severe stenoses give rise to very high velocity gradients at the 
wall because of the no-slip condition.  As long as blood flow at the entrance to the 
stenoses is fully developed, then the velocity profiles may be assumed to be parabolic at 
the entrance based on Poiseuille flow.  The velocity profiles at the throat of the stenosis 
will be top hat shaped with a blunt distribution of velocities in the central jet and a high 
velocity gradient at the walls.  A strong shear layer develops as a result of the high 
velocity gradient.   
 The location of maximum wall shear for steady flow is upstream of the throat of 
the stenosis in the converging region [35].  The exact location of the maximum wall shear 
is a function of the degree of stenosis and is independent of the Reynolds number [36].  
Although the magnitude of the maximum wall shear rate can be shown to vary by the 
square root of the Reynolds number [36].  In estimating turbulence, the critical upstream 
Reynolds number is ~300 [37].  Flow separation occurs in the diverging region of 
stenoses because of the abrupt expansion.  In axisymmetric models, this phenomena 
occurs for Reynolds numbers greater than 10 for severely stenotic vessels (~89% by area) 
and greater than 200 for mildly stenotic vessels (~56% by area) [37].   
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 Strony et. al. determined that peak shear rates in vivo may be approximately 
90,000/s and that the platelet-rich thrombi that occluded the vessel was attached at the 
point where shear rate was highest [38].  Platelet adhesion to thrombogenic substrates is 
shear dependent and accumulation of platelets increases with high shear rates.  The time 
scale of adhesion has been estimated to be on the order of milliseconds [9].  Therefore the 
adhesion strength of platelets to the substrate must be great enough to offset the high 
shear rates in the throat.   
 The formation of thrombus to complete occlusion illustrates the adhesion of 
platelets under extremely high shear well because as the thrombus progressively narrows 
the lumen, the shear rates theoretically approach infinity.  Folts developed an in vivo 
animal model to study the formation of thrombi and it has been used in a number of 
relevant studies [39].  Merino et. al. demonstrated that angiographic filling defects or 
total occlusion occurred in 6 out of 8 severe stenoses (>70% by diameter) which applied 
approximately 5,000/s shear rate in contrast to 1 out of 14 arteries that occurred in mild 
stenoses (<70%) [40].  They also concluded that greater depth of arterial injury enhanced 
platelet deposition and under critical shear conditions may progress to total occlusion.  
Total occlusion in the Folts model is atypical.  More commonly, coronary blood flow 
reductions (CFRs), that occurred when thrombus formed until flow cessation and then 
embolized in a cyclical manner, were used to interpret thrombosis [38, 39].   
 The location of total occlusion is most commonly at the throat of the stenosis.  




 In assessing the change in platelet accumulation under shear stress it is necessary 
to mimic a physiologically relevant substrate along with hemodynamics.  Collagen is 
contained in the basement membrane of the tunica intima and has been shown to cause 
irreversible aggregation in comparison to damaged subendothelium that has platelet 
deposition two orders of magnitude lower [41]. 
 Thrombosis is more likely to occur in regions of high shear and in high grade 
stenoses that have a smaller volume required for thrombus to occlude the lumen.  But if 
these were the only two criteria, then capillaries would be at a high risk of thrombotic 
occlusion.   
 
Platelet Deposition under High Shear 
 One way of looking at platelet deposition is in three phases that have been the 
trend for many experiments with continuous measurement of platelet deposition over 
time [41, 42].  Figure 2 below describes platelet deposition over time and three phases 
that tend to occur.  A more in depth analysis of these phases may be found in Dr. 













































Figure 2.  Three phases of platelet deposition over time.  Curve interpreted from Markou 
et al. 50% by area axisymmetric stenosis.  Shear rate 900/s.  [42]  
 
 After an initial delay in the accelerating phase, platelets accumulate at an acute 
rate until total occlusion or until the amount of platelet deposition reaches a plateau.  The 
decelerating or slow phase may be a result of a state of balance where the rate of platelet 
accumulation equals the rate of embolization.  The acute phase has a linear trend and an 
acute phase constant can be interpreted from the slope of the curve in this phase.  Markou 
et. al. showed that higher shear in 75% and 90% by area stenoses had greater slope to the 
acute phase [42].  A number of thrombosis models have quantified platelet deposition 
onto collagen under high shear regimes.  A comparison of these studies is elucidated 
below with special attention to any complete occlusions observed. 
 Markou et al. determined that vessel occlusion stemmed from platelet deposition 
at the apex of the stenosis which corresponded to the highest shear region, as opposed to 
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the upstream or downstream sides, that had recirculation and low shear [42].  Their 
experiments included an ex vivo baboon shunt with non-anticoagulated blood for two 
hour observation periods.  They measured platelet deposition using 111In-platelet imaging 
with a gamma camera in collagen coated straight tubes (4mm, 3mm, and 2mm ID) and 
axisymmetric sinusoidally-shaped stenoses (4mm upstream ID with 50%, 75%, and 90% 
stenosis by area).  Platelet deposition typically led to full occlusion for shear rates greater 
than 2120 s-1 in 25 minutes or less.  Shear rates were spatially averaged and reached 
7,500/s in the 90% stenosis. 
 Barstad et al. also noted some areas of thrombotic occlusion in the cross-sectional 
area of his flow channel, although the average thrombus occlusion only filled half of the 
area [44].  Non-anticoagulated human blood was perfused ex vivo over collagen type III 
in a eccentrically stenotic flow chamber for 5 minutes.  They observed increased platelet 
deposition between shear rates of 2600 s-1 and 10,500 s-1 by morphological analysis, but 
observed a drop in thrombus volume at 32,000 s-1.  They concluded that the reduced 
thrombus growth at the most occlusive stenosis, 89% by area, was due to the high shear 
stresses that either reduced platelet deposition rate or caused the tear off of thrombus 
fragments. 
 Sakariassen et al. in an equivalent flow chamber and thrombosis model showed 
that thrombus volume increased due to the effect of shear rate up to 2600 s-1  [45].   
Thrombus volume decreased as a result of anticoagulation with citrate, although platelet 
adhesion, measured as surface coverage, did increase with citrated blood in comparison 
to non-anticoagulated.  In this study, he used a conversion of 90 billion platelets/mL 
which was validated in previous work [46]. 
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 Badimon et al. found that platelets accumulated on collagen Type I according to a 
power type curve over exposure time [41].  Interestingly, they concluded that platelets 
did not reach a saturation level even after long perfusion times of 30 minutes and high 
wall shear rates of up to 3380 s-1.  Their ex vivo swine model used heparinized blood with 
radioactively labeled platelets perfused over deendothelialized pig aorta or collagen 
strips.  In comparison to the damaged subendothelium, they found greater platelet 
deposition to the collagen surface by two orders of magnitude and an irreversible 
adhesion of platelets.  In the collagen strip experiments, they found occasionally that 
thrombi ‘completely spanned the lumen of the chamber, without being removed,’ 
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Figure 3.  A compilation of platelet deposition onto collagen as a function of shear rate at 
5 minutes of exposure time by several investigators.  Platelet deposition rate at 5 minutes 
was calculated from platelet deposition data using a straight line method or differentiation 
from regression curves. [41, 42, 44, 45] 
 
To summarize, it is known that platelet deposition increases for shear rates 
ranging from 100 s-1 to 10,500 s-1 for perfusion times of 5 minutes.  A similar analysis of 
these studies was done by Dr. Wootton [9].  The one thrombosis model that estimates the 
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effect of shear rates as high as 32,000 s-1 on platelet deposition is that by Barstad.  The 
reduced thrombus growth in his most occlusive stenosis (89% by area) led him to 
conclude that the high shear rates may have reduced the rate of platelet incorporation 
and/or caused the embolization of thrombus [44].  If high shear rates caused reduced rate 
of platelet deposition then platelets may have saturated their potential to attach in this 
environment.  And if the reason for reduced thrombus volume was due to embolization 
and this occurred in vivo, then the adhesive strength of platelets may be at its threshold.  
The phenomenon of platelet attachment under high shear stresses does occur in vivo 
therefore understanding the nature of platelets in this scenario is critical.   
The rate of platelet deposition from the second phase of Figure 2 may be a useful 
rate to compare among thrombosis studies because the linear growth of thrombus is 
dependent on shear.  Caution should be taken in order to compare platelet deposition 
across studies because thrombosis models vary in blood source, anticoagulation and 
exposure time which clearly have an effect on thrombus formation.  Therefore taking the 
rate of platelet deposition at a fixed time may not capture the maximum rate of deposition 
under respective conditions.  In some of the cases in Figure 3, the maximum platelet 
deposition rates for a certain time are compared against the minimum for another model.  
The Barstad and Sakariassen studies only had three data points over time because they 
measured platelet deposition based on light microscopic morphometry.  In the Markou 
and Badimon studies, radioactively labeled platelets provided a direct measurement of 
platelet deposition.  In these studies, platelet deposition follows an s-shaped curve like 
Figure 2.  Another important comparable amongst these studies and one of the most 
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clinically relevant endpoints is the eventual total occlusion, which may even be reached 
at lower shear rates given a long enough time span. 
 Sukaveneshar and Solen concluded that in the downstream region of stenosis, 
high shear stress decreased thrombus accumulation and increased embolization because 
thrombosis was 60% less in stenotic versus non-stenotic flow [47].  In their tubular 
stenotic flow loop they assessed thrombosis downstream of the stenosis using a substrate 
that was a stent deployed in PVC tubing and thrombosis was evaluated from the weight 
of thrombus attached to the stent.  Their conclusion may be true for flow in the 
downstream region but it is not pertinent to clinically relevant thrombus accumulation 
which occurs at the stenosis throat.  The interesting result of their research was that flow 
disturbances associated with stenoses enhanced embolization from the stents [48].  They 
measured embolism with a light scattering microembolic detector (LSMD).  Embolism 
can be difficult to quantify and is dependent on the substrate used.   
 Glass tubes are a versatile way of studying thrombogenesis in stenotic flow 
because development of thrombus can be visualized by increased translucence as in this 
work or by fluorescence.  Fluorescent labeled antibodies directed against species of 
interest such as platelets, tissue factor, and fibrinogen can be imaged with fluorescence 
microscopy.  Studies that use intravital microscopy in mice visualize thrombus formation 
in arterioles which are on the order of 100 µm [34, 49].   
 
Adhesive Strength of Platelets 
 In recent thrombosis research, one goal has been to measure the strength of the 
adhesion between platelet receptors and surface ligands at the receptor level.  One goal of 
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this research has been to identify the most important domains on adhesive proteins so that 
they may be blocked in order to weaken the adhesion strength and reduce thrombosis.  
Another outcome however, may be to link the maximum platelet strength with the ability 
of platelets to adhere under the high shear conditions before total occlusion as described 
earlier. 
 The platelet adhesive process is regulated by multiple ligand-receptor interactions.  
The initial adhesion of platelets is characterized by the spreading of platelets and is 
mediated by the binding of vWF to integrin αIIbβ3 [50].  Research by Yoshioka et. al. 
demonstrated that platelets with diameter greater than 2.5 µm which represented spread 
platelets had greater strength and more irreversible adhesion to collagen than non-spread 
platelets which had a lesser diameter [51].  The time-dependent accumulation of 
fibrinogen increases the thrombus strength and height resulting in 3-dimensional 
thrombus development [50]. 
 The adhesion strength of platelets increases under greater initial shear rate.  Wu 
and Sixma perfused platelets onto fibronectin, laminin, fibrinogen, vWF, endothelial cell 
matrix (ECM), and collagen type III surfaces under different shear rates and then 
attempted to detach the platelets under various shear rates [52].  They found that at a 
shear rate of 300/s the firmest platelet attachment was to ECM and collagen III, and then 
vWF and fibrinogen, and then fibronectin and laminin.  Diverse cellular responses are 
modulated by the surface chemistry of the substrate and may influence the adhesion [53]. 
 Platelet deposition on collagen depends on the concerted involvement of GPIbα, 
GPIa/IIa, and GPVI [54].  The complete eradication of thrombus formation was achieved 
in human blood flow over collagen by the coinhibition of GPVI with either GPIbα or 
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GPIa/IIa [54].  GPVI has been associated with the ‘second wave’ aggregation response 
under flow, whereas GPIbα and GPIa/IIa mediate the primary adhesion.   
 The detachment of platelets is approximately linear with shear stress.  This was 
evident in Siljander’s experiments and in experiments by Kumar and Arya who measured 
the strength of the GPIbα-vWF bond using shear stress under flow and optical tweezers, 
respectively.  Kumar found that ~50% of platelets detached when increasing shear stress 
from 0.5 to 32 dynes/cm2  [55].  Doggett also measured GPIbα-vWF tether bond strengths 
between 36 and 217 pN with a similar technique of flow dependent adhesion and utilized 
the Bell model to calculate adhesion force [56].  The Bell model determines the 
detachment strength by the rupture force between cells.  Arya measured the force 
required to break the vWF-GPIb-IX bond with optical tweezers and determined that it 
was on the order of 11 pN [57, 58]. 
 Platelet adhesion has been studied at the level of the protein but clinical 
manifestation is at the macroscopic level.  Therefore a study that measures the adhesive 
strength of platelets under physiological conditions is useful in determining the strength 
of glycoproteins and the saturation point of a platelet. 
 
Propagating Fibrin tails 
 In some cases of thrombosis in arterial stenotic flow, a propagating tail of 
thrombus has been observed distal to the adhered thrombus.  Brown et. al. observed 
propagating thrombus in vivo when they administered streptokinase to patients during 
acute myocardial infarction.  When viewed at high magnification, they saw the proximal 
part of the thrombus adhere to the site of atherosclerotic arterial narrowing in 29 of 32 
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cases and in 55% of these cases the thrombus extended downstream in a large ‘tail’ of 
thrombus [59].   
 In non-anticoagulated ex vivo studies with detailed flow conditions, fibrin tails 
have also been observed but under different conditions.  In Markou’s study, fibrin tails 
were observed at lower shear 265/s and 630/s (in the 4mm and 3mm straight tubes) and 
not in higher shear experiments or stenotic experiments [42].  In contrast, the Barstad 
study observed fibrin tail downstream to the collagen-attached platelet thrombus that was 
regularly observed for high-shear stenoses (10,500/s and 32,000/s) [44].   
 Propagating tails may present a hazardous condition because of two possibilities.  
First, they may lead to blockage of flow near the site of attachment by lengthening the 
thrombogenic surface by the formation of a windsock or sheet.  And second, they may 
embolize and block flow downstream.  Various factors of stenotic flow influence the 
propagation of thrombus including shear rate and flow separation with a recirculization 
zone that may increase the residence time of species.  
 
Specific Aims and Hypotheses 
(1) Develop an in vitro model of occlusive thrombosis in stenoses under high shear.  
It is hypothesized that occlusive thrombosis occurs and may lead to complete occlusion 
under high shear.  Porcine blood is harvested, anticoagulated with heparin and perfused 
through glass tubes with hour-glass-shaped stenoses coated with collagen Type I.  Each 
glass tube has a preexisting stenosis and its severity varies so that higher percent stenoses 
produce higher shear rates on the blood.  Pressure and flow rate measurements as well as 
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direct visualization are made to determine the occurrence of occlusions which led to flow 
cessation. 
 
(2) Determine the effect of high shear rate on the rate of platelet deposition until 
flow cessation.  It is hypothesized that the rate of platelet deposition increases with 
increased shear rate beyond 32,000/s.  Platelet deposition is quantified in two ways using 
a model based on the flow rate measurement and another model based on images of the 
stenoses region taken during the experiment.  Results from these experiments in addition 
to results from similar studies found in literature are used to address the effect of shear 
rates of this order on the rate of platelet deposition. 
 
(3) Determine the force required for thrombus detachment.  It is hypothesized that 
thrombus that completely occludes the stenosis is removed at a maximum upstream 
pressure.  The adhesion strength of thrombus attached to the surface is estimated based 
on a force balance given the maximum pressure recorded, the geometry of the stenosis 














 The purpose of this work was to create completely occlusive thrombus under high 
shear and to measure the force required to detach the thrombus.  A flow system with 
arterial stenotic flow conditions was designed and a model of blood flow rate as a 
function of percent stenosis was produced and validated for this system.  Next, platelet 
deposition was assessed using the flow rate model and images taken during thrombus 
formation.  This thesis consists of three sets of experiments with some common protocol.   
 
1 – In Vitro Model of Occlusive Thrombosis 
 This model of occlusive thrombosis in stenoses under high shear was developed 
to study thrombus formation in the stenosis region.  Using this model, a curve of flow 
rate as a function of percent stenosis was generated by perfusion of water or freshly 
harvested blood through collagen-coated glass test sections of varying percent stenosis.  
Therefore given a measurement of flow rate, the model may be used to interpret the area 
of the lumen after thrombus formation.  The flow system was designed to be laminar for 
water and blood and for flow to be fully developed upon entering the stenotic region.  
Next, test sections were validated and used with water and blood in order to determine 
the pressure and flow for various percent stenoses.  The effects of collagen coating on the 
test sections were measured.  All test sections that were perfused with blood had color 
images taken after experimentation in order to identify gross thrombus formation.  The 
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markers for occlusive thrombosis include flow reduction, increased upstream pressure, 
and microscopic inspection of the appearance of thrombi. 
 
2 - Thrombus Formation until Complete Occlusion at High Shear Rates 
 The consistent formation of completely occlusive thrombus in vitro is uncommon 
and the purposes of these experiments are (1) to define the factors present and (2) to 
determine the effect of high shear rates on the rate of platelet deposition.  These 
experiments are an isolated set in which a completely occlusive thrombus formed.  
Additional steps were made to study the deposition of thrombus over time and the 
composition of the thrombus.  In some experiments grayscale imaging with a CCD 
camera was used to observe thrombosis in the stenotic region of interest.  This data as 
well as the flow rate model established in the first set of experiments were used to 
describe platelet deposition over time.  Completely occlusive thrombosis was defined by 
flow cessation and thrombus formation across the lumen assessed by visual inspection. 
 
3 – Detachment Strength of Thrombus 
The purpose of these experiments is to remove completely occlusive thrombus 
and to estimate the detachment strength.   Thrombus was detached from the wall by 
increasing pressure upstream with a syringe pump and recording the pressure with a data 
acquisition system.  The adhesive strength between the thrombus and the surface was 
estimated based on the maximum pressure recorded at the time of thrombus removal, the 




The following sections specify the common protocol for these experiments.  And 
then specific experimental protocol will be described. 
 
Blood Samples 
 Whole blood samples were harvested at an abattoir from pigs through a 
jugular/carotid incision following electro-stunning.  The blood was quickly 
anticoagulated with 1000 USP units/mL porcine heparin (Elkins-Sinn Inc. Cherry Hill, 
NJ, via Priority Healthcare) at 0.40% ± 0.02% v/v.  This is equivalent to 4.0 ± 0.2 U/mL 
of blood, a standard form for comparing heparin anticoagulation.  In comparison to other 
studies this is a low but effective dosage chosen to increase the likelihood of thrombosis.  
In a similar porcine ex vivo experiment, 1.37 ± 0.036 U/mL was used and it was also 
concluded that the heparin levels reached did not significantly affect platelet deposition 
results [60].  In human donated blood experiments with an in vitro model of platelet 
deposition on collagen, heparin anticoagulation was 10 U/mL [61, 62].  And in another 
platelet deposition experiment under stasis conditions, 20 U/mL Low Molecular Weight 
Heparin (LMWH) was used [28]. 
The time of harvesting and the exact volume of blood obtained were recorded.  
From each pig, a blood sample of approximately 1000 mL was collected and typically 
four samples were taken in order to improve the likelihood that one or more of the 
samples would not be coagulated or have small aggregates by the time experimentation 
began.  Each sample was numbered 1 through 4 and kept in a thermos during transport to 
Georgia Tech.  
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Blood samples were assessed upon arrival at Georgia Tech with regards to the 
presence of coagulation, floating aggregates and bubbles and the condition was recorded.  
If a sample was clear of visible fragments, then any bubbles were cleared along the 
surface of the container using a paper towel.  The selected sample was mixed with a 
nutating mixer (Shelton Scientific) at 42 rpm for 15 minutes prior to experimentation.  
Blood aliquots were taken before and after experimentation for measurement of 
hematocrit, platelet count, and mean platelet volume in a Coulter Counter.  Experiments 
were conducted at room temperature and were completed within four hours of harvesting. 
 
Viscosity Determination 
 Viscosity was calculated based on the hematocrit of each sample.  Hematocrit is 
the relative volume of erythrocytes, commonly called red blood cells, reported as a 
percentage of the whole blood volume.  Hematocrit measurements for each blood sample 
from a Coulter Counter were used to compute dynamic viscosity based on Einstein’s 
method of combining plasma viscosity and hematocrit (HCT) [63].  Einstein’s equation is 
expressed in Equation 2. 
 
    )5.21( HCTplasmablood ×+= µµ   Equation 2 
 
where µplasma is 1.7 cP based on the dynamic viscosity of porcine plasma measured at 
900/s in a cone-plate type viscometer [64].  This method is an underestimation of 
viscosity for Hematocrit values in the range of 0.2 to 0.6.  The range of porcine 
Hematocrit values was 0.35 to 0.59.  At high shear rates greater than 700/s, whole blood 
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with hematocrit values between 0.3 and 0.6 has a constant viscosity, making it Newtonian 
[65].  Therefore at the high shear rates applied in these experiments the viscosity may be 
assumed to be constant. 
 
Stenotic Test Sections 
 Glass tubes were used because the material is translucent and the stenosis could 
be formed with very narrow throat diameters.  Pyrex boro-silicate tubes of 1.5-1.6 mm 
inner diameter (ID) and 65 mm length were drawn by glass blowing at half the length to 
form varying percent stenosis of approximately 6 mm length.  Figure 4 below illustrates 
the glass test sections. 
 
 
Figure 4.  Stenotic test section.  Scale of stenosis in comparison to a dime. 
 
 The stenosis was axisymmetric and the ends of the tubes were fire-polished in 
order to smooth out any cracks.  The smallest diameter at the throat of the stenosis was 
measured by analysis of microscopic images with software to calculate distance.  Images 
were taken by a Nikon E600 and the 2x, 4x, and 10x images corresponded to 188 
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pixels/mm, 376 pixels/mm, and 471 pixels/mm, respectively.  Grafula software was used 
in combination with known outer diameter measurements with calipers to confirm the 
sensitivity of the inner diameter measurement.  Percent stenosis was calculated by area as 
in Equation 3. 
 









DDStenosis%   Equation 3 
 
where D1 is the inner diameter of the glass tube and D2 is the inner diameter at the throat 
of the stenosis.  The approximate error for percent stenosis by area is 4%, calculated from 
the resolution of measurements and repeated measurements.  For the remainder of this 
thesis, percent stenosis will refer to percent stenosis by area. 
Stenoses that had a non-circular cross sectional area in the stenosis were omitted 
if they did not fit within the standard error of the flow rate as a function of percent 
stenosis curve in Figure 28 in Chapter III or if they were elliptical by visual inspection.  
Stenoses that did not fit on the flow rate versus percent stenosis curve were postulated to 
have elliptical cross sectional area because of the wet parameter.  
Test sections were attached to plastic connectors using heat shrink tubing.  On the 
plastic connector, all test sections were labeled with a number for identification purposes.  
And on one end of the test section, a ‘C’ was written to indicate that collagen was to be 







 A collagen stock solution was prepared to be 1000 µg/mL by diluting 3.1 mg/µL 
Type I purified collagen by Vitrogen 100 (Cohesion, Palo Alto, CA) with deionized 
water.  The stock solution was refrigerated at all times.  Collagen type I was chosen 
because it is the predominant type in atherosclerotic vessels [66].  Collagen was coated 
from the stenosis or midline to the downstream end by injecting 75 µL of stock solution 
into the downstream side of the test section and leaving it in a humid environment for 15 
minutes.  Non-stenotic tubes were marked with a black line at half the length which 
corresponded roughly to the border of collagen coating.  Figure 5 below shows the set up 
for collagen coating. 
 
 
Figure 5.  Collagen was coated in test sections by filling the sections and then letting 
them dry in a humid environment created by rolled paper towels soaked in hot water in a 
closed Petri dish. 
 
 The collagen concentration was determined to be 1000 µg/mL in order to saturate 
the surface of the lumen.  In comparison to similar collagen coating techniques for 
platelet adhesion studies, Ross [62] and Folie [61] used 980 µg/mL and 850 µg/mL, 
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respectively.  No attempt was made to determine the surface density of collagen fibrils.  
After collagen coating, the test sections were perfused with 1-4 mL of PBS and laid flat 
until used in experimentation.  
 
Flow System 
 For each experiment, 240 mL of the working fluid was transferred into a 500 mL 
platelet transfer bag (Baxter-Fenwal, Deerfield, IL).  For the first experiment of each new 
bag, typically a non-stenotic control, an additional 10 mL of fluid was added to fill the 
additional tubing.  If fluid remained in the reservoir after one experiment then the 
required amount was added to return it to 240 mL.  The platelet transfer bag was attached 
to 85 cm of 3 mm inner diameter (ID) vinyl tubing which connected to a three way valve 
with the test section and the pressure transducer.  Figure 6 below shows a schematic of 














Figure 6.  Flow System Illustration. 
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 Pressure upstream of the stenosis was recorded with a pressure transducer 
(Harvard Apparatus, South Natick, Massachusetts) and flow rate was calculated from 
measurements with graduated cylinders and a stopwatch, each at intervals of 15 seconds 
until flow cessation or the contents of the fluid reservoir were emptied.  The pressure 
transducer was calibrated with a water column and the pressure (mmHg) 
was equal to 0.91 × (pressure reading) - 0.56.  Direct observation of the amount of 
thrombus formation was identified by removing the test sections after experiments and 
imaging them under a Nikon E600 microscope.  In cases where emboli or thrombus 
completely occluded the throat, images were taken without removal of the blood.  In 
cases where complete occlusion did not occur, test sections were perfused with 1-4 mL of 
formalin by dripping the solution through the sections. 
The platelet transfer bags used as a fluid reservoir were donated by the American 
Red Cross of Atlanta and were used because of PL 146 plastic surface, zero contact 
between blood and air, and disposability.  The fluid reservoir laid flat and was elevated 
30 cm above the plane of the pressure transducer and stenosis because both water and 
blood had laminar flow in high grade stenoses at this height.  If the reservoir was reduced 
by 220 mL, the height of the fluid reservoir changed by 1.5 cm during the experiment.  
This corresponds to 1 mmHg pressure change and since this is within the error of the 
pressure measurements, the pressure change may be considered insignificant until the 




Figure 7.  Experimental set up shows two platforms separated by 30 cm, with a 
graduated cylinder and a stopwatch below.  On the middle platform, the test section is 
illuminated by a light source arranged below and a microscope with an attached CCD 
camera is positioned above it.  Experiment photographed December 15, 2004. 
 
Cleaning and Sanitization  
 Platelet transfer bags, tubing, and 60 mL syringes were disposed of after 
completion of experiments with each blood sample.  Pressure transducer parts and test 
sections were cleaned with bleach and hot water until November 30, 2004.  After this 
time, test sections and any additional equipment were sanitized in a Branson Sonicator 
1210 (Bransonic Ultrasonic Cleaner, Danbury, CT) with Cidex solution (Advanced 
Sterilization Products, Irvine, CA).  Cidex solution was diluted with water to a 1:4 ratio 
and disposed of after each use.  The Cidex stock solution was disposed of after 14 days as 
recommended by the manufacturer.  Often the plastic connectors and heat shrink tubing 
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would disconnect from the glass tube during sonication therefore test sections were 
sonicated one a time to prevent confusion in identification. 
  
Water Flow Experiments 
 Water was perfused through each test section in order to (1) determine the height 
of the fluid reservoir and (2) generate a flow rate curve dependent on the percent stenosis 
of each test section.  For each test section manufactured, excluding those that were 
visibly eccentric, two experiments lasting 2 minutes measured the flow rate and upstream 
pressure at 15 second intervals.  2 minutes was sufficient because it was the time elapsed 
before non-stenotic tubes had emptied 200 mL and had an approximately constant 
upstream pressure in this period.  The average flow rate and standard deviation were 
calculated for each experiment and then the average of the two experiments was used to 
generate a curve of flow rate as a function of percent stenosis.  The flow rate curve was 
used to verify that the measurement of percent stenosis corresponded with the flow rate 
measured.  Test sections that had flow rate measurements that did not fit the general trend 
of the flow rate curve were measured a second time for percent stenosis and inspected to 
determine if the throat of the stenosis had a non-circular cross sectional area.   
 
Blood Flow Experiments 
 Whole blood was perfused through the flow system until the fluid reservoir was 
emptied or flow cessation occurred.  The fluid reservoir was refilled with the volume 
perfused after each experiment using a 60 mL syringe.  Blood that had been perfused was 
disposed of according to Georgia Tech Biohazardous Waste Protocol and was never 
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recirculated.  If experiments lasted longer than approximately 8 minutes then the platelet 
transfer bag was gently massaged every few minutes to keep the blood from separating.  
For each blood sample, a non-stenotic tube was used first until bag drainage as a control 
before perfusion of stenotic tubes.  Experiments that had a non-stenotic experiment which 
had a change of upstream pressure equal to 2-3 mmHg before 200 mL of blood was 
perfused were omitted.  All experiments were performed at room temperature and were 
completed within approximately four hours of harvesting. 
 Experiments were identified by a sequence of four numbers separated by periods 
or dashes.  The first two indicate the month and day of the experiment.  The third number 
identifies the pig sample, 1 through 4, and the fourth corresponds to the number of the 
test section.   
Once a test section was perfused once, it was not reused on that day so that it 
could be cleaned sufficiently.  When emboli caused a blockage in the stenotic test 
section, the experiment was completed and no attempt was made to continue testing.  
After two experiments had emboli, it was concluded that the sample was deficient and 
another blood sample was used. 
In order to be fully developed by the time blood reaches the stenosis, the inlet 
length of the glass tube must match the inlet length required by Targ’s equation [67], 








where R is the tube radius, Re is the Reynolds number, and L is the inlet length required 
for fully developed flow.  This is roughly 10 times the diameter. 
The Fahreus effect may be excluded in this analysis because under the designated 
flow conditions the relative hematocrit in the tube is constant for all reservoir hematocrits 
[65].  Whereas the hematocrit is constant, it follows that the apparent viscosity should 
also be constant.  In tubes, the apparent viscosity decreases with decreasing blood vessel 
diameter due to the Fahreus effect of lower tube relative hematocrit especially with 
hematocrits less than 0.3 and tube diameters less than 100 µm [65].  In these experiments, 
the hematocrit of blood samples was between 0.35 and 0.59 and the smallest initial 
diameter at the throat of the stenosis was 310 µm.   
Average flow rates and average upstream pressures were calculated based on the 
time period when the change in pressure was < 1 mmHg for test sections with a stenosis 
and based on the time period when the volume perfused was less than 200 mL for non-
stenotic test sections.  Therefore the time period would last from the beginning of flow 
measurement until the change in pressure was ≥ 1 mmHg for more than one 
measurement.  During this time period, the flow could be considered to be conserved.   
During experiments that lasted longer than 10 minutes, the blood bag required 
mixing by gently massaging every 8-10 minutes.  The time of each mixing was noted in 
the lab notebook.  In a few experiments, when the bag was not mixed and the blood 
separated so that plasma was flowing through the tube, the upstream pressure decreased 





Thrombus Formation Imaging 
 Grayscale images of the region of stenosis or of the midline marking in non-
stenotic test sections were taken on the same 15 second interval as pressure and flow data 
were recorded.  Images were acquired with a Basler 504k CCD camera mounted to a Carl 
Zeiss Stemi 2000-C microscope with a 2.5x extension.  XCAP for Windows was used to 
snap pictures until 2-4 minutes after flow cessation.  Test sections were placed in an oil 
immersion chamber filled with glycerin (Refractive Index = 1.47, matching Pyrex glass) 
in order to obtain two dimensional views of thrombus formation in the stenoses.  For data 
up to and including December 20, 2004, the microscope was set to 1x magnification 
corresponding to 260 pixels/mm.  For experiments after that, it was set to 1.6x 
magnification corresponding to 420 pixels/mm. 
 
 
Figure 8.  Image of thrombus formation visualization set up.  A CCD camera on the 
microscope is attached to a computer with imaging software.  Equipment photographed 




 For these experiments, after blood flow was initiated by opening the valve from 
the reservoir, the equipment was adjusted so that the stenosis was centered with the 
camera and the light source.  In some cases, this took up to thirty seconds.   Once 
adjusted, the stop watch was started and measurements of pressure and flow began.  The 
light source was a twin head lamp by Reichert:Jung (Cambridge Instruments Inc., 
Buffalo, NY) which has two flexible heads that may be bent into position.  The head of 
one of the lights was positioned under the platform that held the test section and was 
pointed straight up towards the camera.  The circular head was positioned so that the 
center coincided with the center of the stenosis or midline for non-stenotic tubes.  Light 
intensity was determined by increasing the intensity until the walls of the lumen could be 
seen clearly using live imaging.   
 In all cases, these images were made into movies by importing image sequences 
into Apple QuickTime version 6.3.  A selection of these movies can be found in Chapter 
IV. 
 
Thrombus Removal Experiments 
 These experiments measured the upstream pressure required to remove thrombus 
stuck in the stenosis throat.  Using a syringe pump, upstream pressure was increased 
slowly until flow returned in the stenosis in an effort to detach the thrombus from the 
wall.  A Harvard Apparatus (South Natick, MA) withdrawal/infusion pump was used to 
raise the pressure at a constant rate and the changes were measured with a pressure 
transducer upstream of the stenosis.  A 5cc syringe was used in the infusion syringe pump 
and the flow rate was determined by the gear used.  In the 12-1 and 12-15 experiments, 
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the flow rate was 0.68 mL/min configured in 4th gear at 100% speed; and in the 12-8 
experiments, the flow rate was 0.34 mL/min configured in 5th gear at 100% speed.  These 
experiments were conducted following blood flow experiments that led to complete 
thrombotic occlusion.  All thrombus removal experiments were completed within six and 
a half hours of blood harvesting and were done within three hours of the thrombotic 
occlusion.   
 The output voltage of the pressure transducer was recorded and converted into 
units of pressure using a data acquisition system.  A LabView program called 
DAQ_ANAL was used to record the voltage input and convert the value to pressure in 
units of mmHg.  Therefore the raw data was output as upstream pressure at a given time 
and recorded every 2 milliseconds for half a cycle.  The data acquisition system was 
triggered to record half of a cardiac cycle, therefore if the cycle designated was 0.8 
seconds then the data would be recorded every 2 milliseconds for 400 milliseconds and 
then stop recording for the next 400 ms.  In order to obtain a continuous pressure curve 
for this steady flow experiment, data during the second half of the cycle was found by 
interpolating between each set of recorded data using the last and first data points 
available.  The program was configured to have a 0.0117 Volt/mmHg input gain in order 
to convert to pressure.   
 The pressure transducer used was another by Harvard Apparatus (Harvard 
Apparatus, South Natick, Massachusetts) and it was calibrated to determine if it was 
linear even at high pressures.  Using a 7 meter water column with measurements every 20 
cm, the pressure transducer was determined to be linear in the range of 0-500 mmHg, as 
shown in Figure 9 below. 
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Figure 9.  Pressure transducer was linear in the range of 0-500 mmHg. 
 
 The circuit board which connected the data acquisition system had a 5 Volt 
threshold, therefore the pressure transducer was zeroed at a negative value in order to 
increase the range of the pressure measurement.  If the pressure transducer was zeroed at 








3-Way Valve Test Section with  
Thrombotic Occlusion
Syringe Pump DAQ 
 
Figure 10.  The thrombus removal system. 
 
 The flow system, illustrated in Figure 10, consisted of the pressure transducer 
connected to a three way valve which connected the stenotic test section and the syringe 
pump.  The flow system was filled with porcine blood and before attaching the test 
section, pressure was relieved by opening the atmosphere end of the pressure transducer 
tubing and zeroing the transducer.  Once the test section was firmly screwed on, the 
tubing on the atmospheric end of the pressure transducer was pinched and a cap was 
fastened.  If the cap was fastened correctly, then the pressure transducer would read the 
same as when zeroed.  If the cap was fastened incorrectly, then the transducer would no 
longer be zeroed because the cap applied a pressure to the closed system. 
 
Histology 
 Samples of thrombus and embolus were fixed in formalin 10% (VWR 
International, West Chester, PA) for at least 72 hours after removal.  Typically, formalin 
fixes at a rate of 1mm/day, therefore for large sections 72 hours was sufficient.  The 10% 
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concentration was used because it was found to be more sensitive to cardiac tissue than 
glutaraldehyde.  Samples were identified by the experiment number.  Samples were 
processed and embedded in paraffin in the IBB Histology Lab.  Paraffin resin is good 
because it does not impair the morphology like freezing.  Deformation of the samples 
during processing may be up to 25%. 
 Samples were cut into 5 micron thin sections either longitudinally or by cross-
section.  Carstairs stain was used to identify platelets, white blood cells, red blood cells, 
and fibrin.  In order to detect expression of von Willebrand factor, an anti-human vWF 
primary antibody (Sigma Product No. F 3520) was also used in an alkaline phosphatase 
detection system.  Staining for most samples was done with a rat heart sample as a 
control because it had a clot with red blood cells and some platelets and fibrin.  A 
coagulated porcine blood sample from this blood source was also prepared as a control in 
order to determine the composition of a clot without shear involved.  Each sample has at 
least two slides with sections corresponding to three areas of the sample.  Each slide has 
10-20 sections that were each 2 µm thick.  In the 12.8.1.9 sample, the downstream side 
was indicated and each slide was separated by 100 µm.  This was the only sample with 
orientation information.   
 Information on the composition of occluding thrombi and emboli was determined 
from image analysis of histological sections.  Images were acquired using a Nikon E600 
microscope, a digital camera and Q-Capture software.   In order to quantify the 
volumetric proportion of species in the thrombi or emboli samples, images were analyzed 
with ImagePro Plus.  The original RGB image was segmented based on four color shades 
and 2-8 indices around that shade.  After color pixels that represented a cell type were 
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segmented, they were isolated by changing them to white and the rest of the image to 
black.  And finally, the number of white pixels was counted with the Matlab code in 
Appendix A-2.  Whereas Carstairs stain shows a lavender color for mix of platelets and 
fibrin, the indices selected also overlapped.  The total number of pixels counted was used 






















RESULTS: MODEL OF OCCLUSIVE THROMBOSIS 
 IN STENOSES UNDER HIGH SHEAR 
 
Thrombus formed in stenotic test sections under arterial flow conditions became 
occlusive and in some cases led to complete occlusion at the throat of the stenosis.   High 
grade stenoses had significantly more thrombus formation than non-stenotic control test 
sections and mild stenoses (defined as stenosis < 80% by area).  The flow system 
produced fully developed blood flow at the entrance to the stenosis and in the stenosis 
throat the Reynolds number was approximately 130 and shear rates were in the range of 
10,000 - 40,000, which is representative of stenotic flow in coronary arteries.  Other 
blood flow parameters compared to normal coronary flow are shown in Table 1 below. 
 














Non-Stenotic Tube 1.5-1.6 31.4 13.5 120 1,500 
85% Stenosis (Throat) 0.61 18.0 16.7 182 13,500 
Left Main Coronary 4 174 80-120 240 460 
Right Coronary 3.4 102 80-120 150 440 
 
 This in vitro model had Reynolds numbers and shear rates representative of 
arterial flow.  Although the flow rates were much lower than in coronary arteries, the 
diameters were also lower which caused equivalent viscous forces in the region of 
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stenosis.  Shear rates were estimated from Poiseuille profile.  The non-stenotic tube in 
Table 1 has presented the average flow rate and upstream pressure for non-stenotic 
experiments (N = 31) and the 85% stenosis has presented the same information for a 
stenotic test section (N = 7). 
Both water and blood were used in this flow system and their data overlapped 
when their corresponding flow rates were normalized by their dynamic viscosity.  When 
the normalized flow rates were presented as a function of percent stenosis, then the 
overlapping curves showed that flow was approximately constant given percent stenosis 
≤ 60% and then it declined approximately linearly until zero flow when the percent 
stenosis was 100%.  Based on this characterization, a model was proposed that used a 
reference measurement of flow rate, normalized by the viscosity, and solved for the 
percent stenosis for stenoses > 85%.  The effective inner diameter of the stenosis throat 
changed during thrombotic occlusion but was solved for based on new calculation of the 
percent stenosis.  This technique of monitoring thrombosis dynamically demonstrated 
that thrombus formation became occlusive and increased resistance in this model. 
 
Blood Flow Experiments 
 Porcine blood experiments had a greater standard deviation in their flow rates 
than water due to the variations in viscosity between blood samples.  In porcine blood, 
the average hematocrit value was 0.468 ± 0.055 for 35 experiments.  The standard 
deviation was as much as 12% of the hematocrit.  The average dynamic viscosity was 3.3 
cP ± 0.1 cP based on calculation from Einstein’s method presented in Chapter 2, 
Equation 2, although each respective viscosity was used for each calculation. 
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The data of blood flow in this analysis comes from all blood flow experiments 
over collagen at a 30 cm reservoir height with the exemption of experiments that had 
embolus blockage within the first minute and non-stenotic controls that had pressure 
changes greater than 3 mmHg before 200 mL was perfused, unless otherwise stated.  This 
includes three days of experiments that had 5.0 U/mL heparin anticoagulation as opposed 
to the standard 4.0 U/mL in the other twenty-three days.  The higher heparin dosage did 
not seem to have an effect on thrombus formation whereas non-stenotic controls showed 
thrombus consistent with other controls.  In one high grade stenosis, thrombosis led to 
complete occlusion under the higher heparin dosage, although flow cessation occurred 
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Average Flow Rate (mL/min) Average Pressure (mmHg)  
Figure 11. The average flow rate and average upstream pressure for blood experiments 
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Figure 12. Average Reynolds numbers (Re #s) for blood flow experiments over collagen. 
 
The flow was considered to be fully developed upon entering the stenotic region 
because the inlet length required by Targ’s equation, in Chapter II Equation 4, was less 
than the length of the upstream side of the glass tube.  From Targ’s equation, the inlet 
length was 1.8 cm based on the upstream Reynolds number of 140.  This entrance length 
was satisfied since the glass tubes had at least 3 cm before the stenosis.  
Each experiment was classified as not occluded (N), occluded due to embolus 
stuck in the stenosis throat (E), or occluded as a result of thrombotic occlusion (TO). 
Emboli were distinguished by an abrupt increase in pressure equal to or greater than 4 
mmHg or occlusion occurring within the first 5 minutes. To ensure that clotting occurred 
in the glass tube and not simply coagulated in the supply tubes, flow was confirmed after 
the stenosis was removed.  Figure 13 below demonstrates that the occurrence of complete 
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Figure 13. Occurrence of complete occlusion increased with % stenosis.   
 
 The number of occurrences of each category was normalized by the total number 
of experiments in each range of percent stenosis.  In test sections with ≥ 93% stenosis, 
thrombosis led to complete occlusion in 5 out of 25 experiments.  And in the second 
range, 2 out of 7 experiments led to complete occlusion in an 85% stenosis.  The number 
of test sections in each range used was 36, 26, 16, and 25 in order of increasing percent 
stenosis.  This histogram was developed from data of all blood flow over collagen with 
the exemption of experiments that had embolus blockage within the first minute and non-
stenotic controls that had pressure changes greater than 3 mmHg before 200 mL was 






Effect of Increased Percent Stenosis 
 Occlusive thrombosis in stenoses under high shear was achieved using collagen-
coated glass tubes and porcine blood anticoagulated with heparin.  Increased percent 
stenosis and hence, greater shear, led to greater thrombus formation evaluated on a gross 
scale.  Under the microscope, thrombus was visualized on the collagen coated sections of 
the lumen and was especially evident at the beginning of the collagen coating surface and 
at the throat of the stenosis, as seen in Figures 23 and 15, respectively.  Often, thrombus 
accumulated in the converging region of the stenosis as well.   
In each of the following examples, pressure and flow data were for experiments 
that correspond to the images provided.  These microscopic images provided a sufficient 
means to study gross thrombus formation.  These images were representative of the 
majority of the experiments they described and they were not been modified with the 
exception of some cropping in the 2x images.  In 2x images, the perimeter of the light 
source was visible. 
 
Severely Stenotic Experiments 
 Stenotic test sections ≥ 80% remained patent or completely occluded due to 
emboli or thrombotic occlusion which occurred at the throat of the stenosis.  In 
experiments that had thrombus formation to complete occlusion, the pressure increased 
over a few minutes each time in steps which corresponded with lower flow rates during 
these periods.  The formation of a completely occlusive thrombus may be understood 
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Figure 14.  95% stenosis.  Flow rate decreased to zero as the upstream pressure increased 
due to thrombus formation in the stenosis.  Average flow rate was 6.1 ± 2.1 mL/min for 
the first 4 minutes and 45 seconds.   
 
 Precision errors on all flow rate and pressure measurements were ± 2 mL/min and 
± 1 mmHg, respectively.  Observations were made during the experiment because the 
thrombus that formed in the throat could be seen by the naked eye.  The first thrombus 
appeared on the diverging side of the throat and it waved in the flow, eventually 
spreading throughout the throat.  Flow cessation occurred at about 16 minutes, although 0 
mL/min flow was measured from about 15 minutes because the 0.5 mL resolution of the 
graduated cylinder was not small enough to measure single drops.  Figure 15 below 





Figure 15A. 95% stenosis.  2x magnification.  Throat diameter was 350 µm.  Thrombosis 
led to complete occlusion.  Thrombus volume may be visualized because it is translucent.  
Whole blood is opaque and it inhibited view of the whole thrombus. 
 
 
Figure 15B. 95% stenosis.  4x. Thrombus completely crossed the lumen only in some 
areas. 
 
The images in Figure 15 were taken within one hour of the experiment.  In many 
imaging sessions that took place after one hour, the stagnant blood in the test section 
separated and more thrombus could be seen.     
In many experiments, flow cessation occurred as a result of emboli that were in 
the blood and blocked at the throat of the stenosis.  Emboli were distinguished by an 
abrupt increase in pressure equal to or greater than 4 mmHg or occlusion occurring 
within the first 5 minutes. To ensure that clotting occurred in the test section and that 
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flow was not simply blocked in the supply tubes, flow was confirmed after the stenosis 
was removed.  The pressure ramp and flow cessation in Figure 16 below demonstrated a 
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Figure 16. 92% stenosis.  Pressure ramp at 5 minutes demonstrated the blockage caused 
by embolus that led to flow cessation.  Average flow rate was 9.1 ± 2.1 mL/min for the 
first 5 minutes. 
 
With the exemption of a few experiments, emboli blocked flow in the throat of 
the stenosis.  This was the narrowest section of the flow system and emboli occurred 
especially in high grade stenoses.  The particle could be observed in the throat, but the 
first indication was always the upstream pressure.  Experiments that had emboli after the 
first minute were used for the model of flow as a function of percent stenosis described in 





Figure 17. 92% stenosis.  Embolus is visible in the throat.  Whole blood is opaque and 
inhibits view on the sides. 
 
The composition of embolus was evaluated with histology for one experiment in a 
95% stenosis.  The embolus was fixed in formalin, embedded in paraffin, sectioned by 
cross section and stained with Carstairs to identify blood species.  In a color image, seen 
in Figure 18, white blood cells are dark purple circles, red blood cells are red, fibrin is 
purple, and platelets are blue.  Note that in this sample embolus there are no red blood 





Figure 18.  Sample embolus sectioned and stained with Carstairs demonstrated that the 
embolus was a platelet aggregate without red blood cells.  Relative proportion of species: 
WBC 12%, fibrin 37% and platelets 51%.  Sample 11.17.2.7. 
 
Mildly Stenotic Experiments 
 For stenoses less than 80% stenotic by area (~55% by diameter), some thrombus 
was evident from microscopic inspection after experimentation.  Thrombus formation 
was generally focal in nature.  The lumen of the < 80% stenoses remained patent, 
however, or blocked as a result of emboli.  For these experiments, the upstream pressure 
was only slightly greater than the non-stenotic tubes but the flow rate had much less 
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fluctuation.  The increased resistance of the stenosis seemed to damp flow rate.  Flow in 
these experiments dripped from the outlet of the test section. 
Figure 19 below shows how the upstream pressure and flow were affected by 
thrombosis.  The average flow rate for this experiment was 21.7 ± 2.6 mL/min calculated 
over the first 5 minutes and 45 seconds, which was the time period when the upstream 
pressure changed less than 1 mmHg.  Pressure increased by 1 mmHg at 6 minutes as a 
result of thrombus formation in the stenosis.  In experiments with less thrombus, the 
upstream pressure remained constant.  Images of the thrombus are in Figure 20 after the 


































Figure 19. 69% stenosis.  Pressure increased around 6 minutes due to thrombus formed 




 Inspection of the stenosis revealed that almost the entire collagen coated surface 
was covered with thrombus.  Flow was from left to right and on the left hand side of the 
upstream image in Figure 20A, a large amount of thrombus is apparent.  In Figure 20B, 
some of the surface at the throat was clear of thrombus which may have been removed 
during flow.  Focal deposition of thrombus in the throat of the stenosis typically had 
circumferential striations like the two visible on the right hand side.  To illustrate this 
feature further, Figure 21 shows the trend throughout the throat of the stenosis. 
 
 
Figure 20A. 2x magnification.  69% stenosis.  Upstream side of stenosis showed large 
amounts of thrombus at the border of collagen coating and was scattered throughout.  





Figure 20B. 4x magnification at the throat of the stenosis showed that some surfaces 
were completely clear of thrombus which may have been removed in flow. 
 
 
Figure 20C. 10x magnification. Close up on the border between the cleared surface and 
thrombus.  Image was magnified from Figure 20B at the top portion.  Note the two 
circumferential striations of thrombus on the right hand side. 
 
Thrombus formation was non-uniform along the length of the stenosis.  The 
thrombus volume was great enough to occlude the pathway of blood and cause an 
increase in upstream pressure.  Figure 21 presented another experiment where parallel 




Figure 21. 62% Stenosis.  2x. Striations of thrombus were visible in the throat.  This test 
section was photographed without the oil-immersion bath therefore the walls of the glass 
tube appear black. 
 
Non-stenotic Experiments 
 At the beginning of each set of experiments, a non-stenotic or straight test section 
was tested in order to confirm that the upstream pressure was approximately constant, to 
compare differences of viscosity in experiments, and to compare the increased resistance 
of adding stenosis.  Figure 22 below shows how the flow rate was approximately constant 
during a typical experiment until the blood reservoir, holding 240mL of blood was 
reduced by 200 mL, at 6 minutes for this experiment.  Average flow rate and upstream 
pressure were calculated for this time period because they could be considered to be 
conserved.  The average flow rate for this experiment was 33.1 ± 4.9 mL/min.  Between 4 
and 6 minutes the flow became more irregular and flow rate fluctuated more.  The 









































Figure 22. Non-stenotic experiment.  Error bars calculated on measurement resolution.  
Pressure and flow rate dropped to zero once the contents of the reservoir emptied. 
 
For non-stenotic experiments, the averages of flow rate and upstream pressure 
were calculated based on measurements made while the volume perfused was less than or 
equal to 200 mL.  This typically matched the time that the pressure changed by 1 mmHg 
for more than 30 seconds.  Reynolds number for these experiments was 139 ± 29.  
Images taken for this same experiment, shown in Figure 23, indicate that thrombus 






     Figure 23A        Figure 23B 
Figure 23. 23A was 2x; 23B was 4x magnification.  Thrombus was visible on the surface 
of the right hand side of this non-stenotic tube that corresponds to the beginning of the 
collagen coated surface.  The black marking on the glass indicated the midline and the 
border of coating.  Flow was from left to right. 
 
In Vitro Model of Occlusive Thrombosis 
 The blood flow experiments demonstrated that greater amounts of thrombus 
formed on collagen coated glass tubes when the shear rate was increased and that some 
experiments led to complete occlusion.  Based on the data from these experiments, a 
model of flow rate as a function of resistance was developed and demonstrated to work 
for blood and water.  Given the viscosity of the fluid and a measurement of the flow rate, 
the percent stenosis can be predicted.  This model estimated the effective diameter of the 
stenosis throat after it has been narrowed as a result of thrombosis.  Data used in the 
validation of this model were from measurements of flow rate in collagen-coated water 
experiments and all collagen coated blood flow experiments with the exemption of (1) 
experiments that had a non-stenotic control which had an upstream pressure that 
decreased more than 3 mmHg before 200 mL was perfused, and (2) experiments that had 
an embolus cause flow cessation before the first minute of flow.  This data includes some 
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experiments that had 5 U/mL heparin for three dates of experiments: 8-30-04, 9-1-04, and 
9-3-04.   
The flow rate curves overlapped for water and blood when they were normalized 
by their dynamic viscosity and were plotted as a function of percent stenosis.  The curves 
show that flow was approximately constant given percent stenosis ≤ 65% and then it 
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Figure 24.  Blood and water normalized flow rates were approximately constant until 
around 65% stenosis and then they decreased linearly until 100% stenosis.  The flow rate 
for each fluid was normalized by its viscosity and reported as mean ± 1σ. 
 
 Many of the stenoses had normalized flow rates that matched well for blood and 
water.  At greater percent stenosis, the normalized flow rates for blood were higher than 
water which may have been a result of fluctuation of blood viscosity.  Using the data for 
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blood alone, a more exact characterization of flow rate in severe stenosis is presented in 
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Figure 25.  Flow rate model for blood in stenoses ≥ 85%.  Linear approximation has R2 = 
0.94.  Data presented as mean ± 1σ. 
 
 A boundary condition was imposed on the empirical data for this linear 
approximation so that at 100% stenosis there was zero flow.  Consequently, the x-
intercept at 100 % was included because logically there was no flow once the lumen 
closed.  This condition was imposed by reversing the coordinates, setting the y-intercept 
to 100, and finding the best-fit line.  Since the square of the correlation coefficient was 
0.94, the linear assumption in this region was a good approximation.  The equation of this 




    100)(%314.12 +×−= StenosisQµ   Equation 5 
 
where Q was the flow rate and µ was the dynamic viscosity of blood and % stenosis was 
calculated by area.  Based on Equation 5, it was possible to solve for percent stenosis 
greater than 85% for a given flow rate and viscosity.  For blood flow in this model, the 
upstream diameter was constant whereas thrombosis only occurred significantly on the 
collagen coated surface which began just upstream of the stenosis.  Therefore since the 
only variables during thrombosis in this model were the flow rate and the throat diameter, 
it was possible to recover throat diameter for flow rates at a particular time.  The 
assumption of this flow rate model was that reduced flow as a result of thrombus 
formation followed the flow rate curve which was developed by imposing increasing 
symmetrical area reductions.  Platelet deposition was quantified based on knowledge of 
the throat diameter at different times during the experiment and the initial geometry of 
the stenosis.  Platelet deposition and formation of completely occlusive thrombus will be 
analyzed in Chapter IV.   
 
Effect of Coating Collagen 
 Non-collagen coated stenoses did not show significant signs of thrombus 
formation.  The upstream pressure decreased over time because the height of the fluid 
reservoir changed by 1.5 cm by the time 210 mL of blood was perfused, corresponding to 
1-2 mmHg change.  In a 97% stenosis, the lumen remained patent for over 25 minutes 
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and thrombus could not be identified when inspected microscopically, as seen in Figure 




































Figure 27. 97% Stenosis.  Thrombus did not form on the walls of this non-collagen 
coated stenosis.  Throat diameter was 310 µm. 
 
 The surface of the lumen in Figure 27 did not have thrombus that could be 
identified microscopically.  In collagen-coated experiments that remained patent during 
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the flow until the emptying of the reservoir, thrombus formation was always apparent.  At 
higher magnification with use of a marker for blood species, some thrombus formation 
may be evident.  Relative to collagen-coated experiments that remained patent, however, 
this may be negligible. 
In 3 non-stenotic and 9 stenotic experiments of blood flow through non-collagen 
coated test sections, thrombus formation was found in only one.  In the one with 
thrombus, it was determined that the surface was not cleaned thoroughly from the last 
experiment with collagen.   
In comparison to non-collagen coated test sections, the collagen coated sections 
had flow rates within the standard deviation for blood and water (H2O).  Figures 28 and 
29 show the effect of adding collagen to test sections perfused with H2O and blood, 
respectively, at 30 cm reservoir height.  For H2O, the average flow rate was calculated by 
taking the average of two experiments, where each experiment had a mean flow rate from 
8 measurements made every 15 seconds over two minutes.  Three different 0% test 
sections and two different 69% stenoses were tested in order to confirm the performance 
of stenoses with the same measured percent stenosis.  The flow rates and upstream 
pressures measured were within one standard deviation for these.  In order to use their 
data in Figure 8, the three non-stenotic sections were averaged together and the 69% 
stenoses were averaged together.  For blood, the average flow rate was calculated for 
experiments with each stenosis using the methods described earlier for non-stenotic and 
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Non-Collagen Coated Collagen Coated
 
Figure 28. H2O. Addition of collagen does not affect the average flow rate.  Average 
flow rate is reported mean ± 1σ. 
 
Test sections that did not follow the curve in Figure 28 were inspected to 
determine if the cross sectional area at the throat of the stenosis was elliptical.  Five 
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Figure 29. Blood. Addition of collagen to the test sections did not affect the flow rate of 
blood.  Average flow rate reported as mean ± 1σ. 
 
Determination of Height 
 The height of the fluid reservoir drove the flow.  Reservoir heights between 20 
and 35 cm were used to measure the flow rate of water as a function of the percent 
stenosis.  Average flow rate for these experiments was calculated from 4 measurements 
made every 15 seconds for one minute.  After the first minute, volume in the reservoir 
went below 200 mL for the non-stenotic tubes in the 35 cm experiments and flow rate 
changed considerably.  Therefore comparison of these average flow rates is only made 
for the first minute.  Flow rates are reported as mean ± error, where error is defined as 
twice the standard deviation, σ.  Figure 30 shows the average flow rate at three different 
reservoir heights and Figure 31 shows the corresponding Reynolds number (Re) at the 
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Figure 30. Greater heights of the water reservoir produced higher flow rates, especially 
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Figure 31.  Reynolds number at the stenosis throat predicted transitional flow (Re ~1800) 
for experiments at 35 cm and laminar flow for experiments at 20 cm and 35 cm.  
Error on percent stenosis is ± 4%. 
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The 30 cm reservoir height was selected because flow remained laminar without 
becoming transitional when Re ~ 1800 and because the high flow rate produces a high 
shear rate on the fluid.  Flow rates at this height were predicted to produce shear rates in 
the range of 10,000 to 60,000 for blood.   
 
Calculation of Shear Rate and Reynolds Number 
 As blood moved through the flow system, shear stresses were developed due to 
the no-slip boundary condition at the wall.  At the stenosis throat the velocity profile was 
blunt and the shear stress was approximated by assuming Poiseuille flow rather than 
measuring the shear stress which may had an error of 20-50% [7].  Poiseuille flow 
predicts a lower bound of shear stress because it assumes a parabolic velocity profile that 
has a less severe velocity gradient at the wall.  Mean wall shear stress, τ, for laminar 
steady flow in straight tubes or pipes has been approximated as stated in Equation 6. 
 





µτ =     Equation 6 
 
where µ was the dynamic viscosity, Q was the volume flow rate, and D was the diameter 
of the lumen.  The shear rate in this work was calculated from Equation 7 based on 
measurements of Q and D, without taking into account µ. 
 









Reynolds numbers (Re) were calculated based on flow rate using Equation 8. 
 
     
υπD
Q4
=Re     Equation 8 
 
where υ is the kinematic viscosity.  The kinematic viscosity was calculated for each blood 
sample based on the dynamic viscosity divided by the density of blood, 1035 kg/m3.  The 




















RESULTS: THROMBUS FORMATION UNTIL COMPLETE OCCLUSION 
 
Thrombus formation led to complete occlusions in seven experiments using three 
different stenotic test sections.  Two occurred in an 85% stenosis, one in a 95% stenosis 
and four in a 96% stenosis, all occurring in the throat of the stenosis.   Other experiments 
often showed large amounts of thrombus but did not lead to total occlusion.  And in many 
high grade stenoses the occurrence of emboli inhibited the evaluation of thrombus 
formation.  Only blockages as a result of complete thrombotic occlusion will be reviewed 
in this section.   
 The markers for thrombotic formation to complete occlusion included increased 
upstream pressure in steps over time, visible white thrombus on the walls, and flow 
cessation.  Typically, flow did not stop for another minute or longer after the 
measurement of flow rate was zero because a few drops could not be measured by the 0.5 
mL resolution of the graduated cylinders or the presence of flow in the stenosis throat 
was undetectable.  Upon magnification on the stenosis throat, it was found that flow did 
continue even after it was undetectable at the downstream exit.  Table 2 below lists both 
the time when flow rate was undetectable and the time when flow ceased and there were 
no drops and flow could not be seen in the throat.  The time of flow cessation was more 






Table 2.  Data on the seven complete occlusions in order increasing percent stenosis. 
% Stenosis by 
Area Experiment 
Time Flow is 
Undetectable 
(min) 








85 12.8.1.9 11.5 17.5 99 0.4 
85 12.15.2.9 15.75 16.5 108.5 0.36 
95 10.27.4.7 16.5 16.5 65.5 0.36 
96 11.3.3.33 9.25 9.5 35 0.4 
96 11.22.4.33 17.25 18 94 0.36 
96 12.1.2.33 11.75 13 55.5 0.37 
96 12.15.2.33 12.5 13.5 84 0.36 
 
The average time of flow cessation was 13.5, 16.5, and 17 minutes in order of 
decreasing percent stenosis.  Less than 100 mL of perfused whole blood was necessary to 
completely block most of the test sections, where the highest volume required was in the 
85% stenosis which had greater flow rates and a larger lumen for thrombus to fill.  For 
the majority of experiments, 0.40% heparin volume to whole blood volume was used for 
anticoagulation.  Many of the thrombotic occlusions in this model resulted from the 
slightly lower dosage of heparin.  The average Reynolds number was 126 ± 15. 
Thrombus formation images were taken every 15 seconds for the three 
experiments in Table 2, which were completed on December 8th and 15th.  These images 
were used to identify the time of flow cessation as well as visualize thrombus formation 
and measure platelet deposition during the experiment.  A platelet deposition model 
based on these images as well as another platelet deposition model based on flow rate has 
been presented in the following sections. 
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For these experiments, upstream pressure may have been constant without the 
effect of thrombosis.  Upstream pressure rose to 24 mmHg near the time of flow 
cessation which corresponds to a 31.5 cm column of blood, which is consistent with the 
experiment because when the blood reservoir was completely full the highest surface was 
approximately 31.5 cm above the plane of the pressure transducer and stenosis.  After 
200 mL of blood had perfused in the non-stenotic sections, a pressure change of 1-2 
mmHg occurred, but since 100 mL or less was required for these experiments the 
upstream pressure was constant. 
These experiments demonstrate that the components present in completely 
occlusive thrombus include platelets, collagen, fibrin, vWF, and high shear rates.  
Heparin did not limit the formation of thrombus to complete occlusion but the dosage of 
heparin may have played some role based on variation in these experiments. 
 
Platelet Deposition Based on Flow Rate 
 Platelet deposition has been calculated for the seven blood flow experiments that 
led to complete thrombotic occlusion.  The model of flow rate as a function of percent 
stenosis presented in Chapter III determined the effective throat diameter given a 
reference flow rate.  Recall that the model of flow rate predicted that for severe stenoses 
(equal to or greater than 85%) the flow rate could be estimated by Equation 5. 
 In this flow rate model only the throat diameter was necessary to characterize the 
platelet deposition therefore the region of interest was limited to the apex of the stenosis.  
Platelet deposition was solved for by determining the number of platelets deposited at a 
time and dividing by the surface area which the thrombus covered.  First, the volume of 
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thrombus was estimated by assuming that (1) that the thrombus was cylindrically shaped, 
and (2) thrombus formed uniformly and symmetrically in concentric rings on the walls of 
the stenosis.  The volume of thrombus for a particular throat diameter was calculated by 
Equation 9. 
 




2 LDD ×−×= πV    Equation 9 
 
where V is the volume of thrombus, D2 is the inner diameter of the stenosis throat, D2’ is 
the new throat diameter, and L is the length of the thrombus.  The number of platelets 
was calculated by multiplying the volume (V) of thrombus by the proportion of platelets 
in the thrombus, f, and dividing by the mean platelet volume, MPV, as in Equation 10. 
 
    
MPV
VfPlatelets ×=#    Equation 10 
    
MPV was determined from measurement in a Coulter Counter for each blood sample.  
The proportion of platelets in the thrombus, f, was estimated by evaluating the 
histological composition of occluding thrombi with image analysis as described in the 
last section of this chapter: Histology and Composition Analysis.  The range of f for the 
thrombi analyzed was between 75% and 96%.  Platelet deposition, PD, is the 
accumulated number of platelets per surface area in the stenosis and was calculated by 
dividing Equation 10 by the surface area.   The surface area which the thrombus covered 
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was simply π×D2×L based on the cylinder assumption.  The length, L, and π cancel and 
yield Equation 11. 
 












])'([    Equation 11 
 
The maximum platelet deposition can be estimated by setting D2’ to zero. 
 For this platelet deposition model, the time period selected was based on the 
period of each pressure step because pressure is dependent on flow rate.  Although 
pressure and flow are directly related, the upstream pressure was more sensitive to the 
changes occurring in the flow loop.  Figure 32 below illustrates how pressure steps 
increase until flow cessation and it can be seen that the flow rate is reduced until it is 




































Flow Rate (mL/min) P(mmHg)
 
Figure 32.  Flow rate and upstream pressure data for a 95% stenosis experiment that led 
to complete occlusion.  The shear rate was 24,200/s based on the average flow rate for the 
first five minutes.  Experiment 10-27-4-7. 
 
 Precision errors on all flow rate and pressure measurements were ± 2 mL/min and 
± 1 mmHg, respectively.  For each pressure step, consisting of at least 30 seconds length, 
an average flow rate was calculated and a throat diameter was solved for using Equation 
5 and the definition of percent stenosis by area.  Using Equation 11, platelet deposition 
was calculated for each effective diameter corresponding to that time period.  The amount 


































Figure 33.  Platelet deposition during the experiment.  The magnitude of platelet 
deposition corresponded to the throat diameter during that time period.  Maximum 
platelet deposition required to block this 95% stenosis with a 350 µm lumen was 0.96 
billion platelets/cm2. 
 
 For the first 11.5 minutes, platelets deposited on the surface slowly indicating 
accelerating platelet deposition (Phase I from Figure 2) and reduced the effective 
diameter to 300 µm, which raised the percent stenosis to 97% by area (83% stenosis by 
diameter).  The magnitude of platelet deposition initially was nonzero because it was 
based on the average flow rate for the first 4.75 minutes while at a constant pressure, 
therefore the average flow rate for this particular experiment may have been slightly 
greater or less than the flow rate used for a 95% stenosis in the model.  Based on this 
initial difference in flow rate, the platelet deposition resulted in either positive, negative, 
or zero values at the beginning.   
 The platelet deposition doubled between approximately 11.5 and 13.5 minutes of 
flow.  This was representative of the acute platelet deposition, Phase II, when the rate of 
deposition may be linear.  And in the last few minutes of flow the margin between the 
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magnitude of platelet deposition decreased which resembled the slow phase, or Phase III.  
Therefore, for this experiment, the rate of platelet deposition decreased before reaching 
complete occlusion.  This measure of platelet deposition is directly related to the changes 
in throat diameter, therefore the accumulation of platelets in this model is related to the 
change of the effective diameter of the lumen. 
 A useful characterization of platelet deposition is the acute rate of accumulation 
which was determined from the slope of a line fitted to the data between the beginning of 
the acute phase and the time of flow cessation.  In this experiment, the acute phase was 
estimated to begin at 10 minutes and flow cessation occurred at 16.5 minutes.  The slope 
of the line was 113 million platelets/cm2/minute or 1.88 million platelets/cm2/second.   
This model takes advantage of the reduced flow rate for each pressure step and interprets 
the reduction of flow as a decrease in the effective diameter, and hence a greater volume 
of thrombus. 
 Table 3 below compares the acute rate of platelet deposition to the total rate of 
platelet deposition which is calculated using the maximum platelet deposition and a 
straight line estimate over the duration of the experiment until flow cessation.  The total 
rate does not take into account the phases of platelet deposition interpreted in Figure 2.  
Therefore the acute rate of platelet deposition predicts a higher rate because of the 
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y=1.25x+6.05 1.53 17.5 5.5 12.15.2.9 
95 
1.88   
y=1.88x-13.76 
0.91  
 y=0.91x-0.87 0.96 16.5 10 10.27.4.7 
96 
2.39   
y=2.39x-10.54 
1.95   
y=1.95x-7.77 0.64 10 5.25 11.3.3.33 
96 
3.09   
y=3.09x-38.82 
1.56   
y=1.56x-17.12 0.92 18 10.75 11.22.4.33 
96 
2.37   
y=2.37x-1.49 
2.04   
y=2.04x-12.3 0.81 13 4.5 12.1.2.33 
96 
3.6   
y=3.60x-38.76 
1.39   
y=1.39x-12.4 0.78 13.5 7.5 12.15.2.33 
Average 
± S.D. 2.3 ± 0.8 1.6 ± 0.4 1.1 ± 0.4 15.1 ± 3.0   
 The lowest acute rates were for the 85% stenosis and these acute rates were more 
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Figure 34.  Acute platelet deposition rate increased with percent stenosis.  Values 































Figure 35.  85% stenosis.  The initial shear rate was 10,000/s based on the first 3 







 In the 85% stenosis, presented in Figure 35, the rate of platelet deposition was 
more gradual and the acute rate constant was closer to the slope of platelet deposition 
over the whole length of the experiment.  For greater percent stenosis experiments, the 
upstream pressure remained constant longer and then increased in short steps over a short 
amount of time to flow cessation. 
 
Thrombus Formation Movies 
 In three of the experiments that led to complete occlusions, digital images taken 
every 15 seconds, corresponding to pressure and flow measurement, show the 
development of thrombus on the walls of the stenosis throat and ultimately, the thrombus 
growth across the lumen to block flow.  These images demonstrate that the formation of 
thrombus was focal in nature and that thrombus protruded into the lumen at multiple 
sites.  Because thrombus formation was non-uniform along the length of the stenosis the 
pathway of blood may have changed from being axis-symmetric.  
 The following image sequences are in Apple QuickTime *.mov format and may 
be viewed with movie players such as QuickTime or Windows Media Player.  The 
movies were made by combining a sequence of images into a movie file.  The size of the 
movie file is reported in parenthesis and when downloading the file from the internet this 
should be considered with respect to connection speed.  Each of the experiments that led 
to complete thrombotic occlusion have been presented in Figures 36-38 and a patent non-






  Figure 36.  Thrombus formation image sequence in the 85% stenosis at time = 0.  
Throat diameter was approximately 610 µm.  Thrombus may be visualized because it is 
translucent.  Whole blood is opaque and inhibited view of the whole thrombus.  Flow was 
from right to left.  1.0x magnification.  Filename:  85per_sten_TO_40sec_12-15-
9_2fps_C.mov (4.64 MB). 
 
 Four images were taken every minute over 20 minutes for a total of 80 images, 
although presented as in Figure 36 above at 2 frames per second the image sequence lasts 
only 40 seconds.  Flow cessation in the experiment in Figure 36 was at 16.5 minutes 
which corresponds to approximately 33 seconds in the movie.  Observation at this 
magnification was the best method to identify the time of flow cessation whereas flow 
may be undetectable at the end of the glass tube using a graduated cylinder, but may still 
continue in the stenosis throat.  Images were snapped until 20 minutes to capture any 
changes and to ensure that the flow did not restart.  Since flow cessation was at 16.5 
minutes, the last three and a half minutes show blood separation into plasma and RBCs in 
addition to thrombus formation.  The downstream side especially separates quickly. 
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 Another image sequence of the 85% stenosis demonstrates technical issues with 
obtaining these images.  Each test section was immersed in a bath of glycerin between 
two glass cover slips that were connected on one edge with a segment of 4 mm outer 
diameter Pyrex pipe.   Sometimes the surface tension of the glycerin moved the test 
section towards this edge which disrupted imaging. 
 
 
Figure 37.  Thrombus formation image sequence in another 85% stenosis starting at 8.25 
minutes.  Throat diameter was approximately 610 µm.  Thrombus may be visualized 
because it is translucent.  Whole blood is opaque and inhibited view of the whole 
thrombus.  Flow was from right to left.  1.0x magnification.  Filename:  
85per_sten_TO_19sec_12-8-9_2fps_C.mov (2.54 MB). 
 
 The image sequence in Figure 37 above started at 8.25 minutes after some 
technical difficulties and continued until 17.5 minutes.  The stenosis was not aligned and 
the light source was off center.  The thrombus grew in circumferential striations at the 
throat diameter.  The time of flow cessation was identified at 17.5 minutes, although 
images were not taken for long enough because a small area in the lumen was still patent.  
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Flow rate was undetectable at 11.5 minutes therefore it would seem that the last stage of 
platelet deposition which completely blocked the lumen took a protracted time, greater 
than 6 minutes. 
 
 
Figure 38.  Thrombus formation image sequence in the 96% stenosis at time = 0.5 
minutes.  Throat diameter was approximately 310 µm.  Thrombus may be visualized 
because it is translucent.  Whole blood was opaque and inhibits view of the whole 
thrombus.  Flow was from right to left.  Magnified at 1.0x.  Filename:  
96per_sten_TO_39sec_12-15-33_2fps_C.mov (4.21 MB). 
 
 The image sequence in Figure 38 above started at 30 seconds and continued until 
20 minutes.  This image sequence has shown that a thrombus on the converging side of 
the stenosis appeared to migrate into the throat of the stenosis where it blocked flow and 
then thrombus formation increased rapidly.  This particular thrombus was first identified 
at 7 minutes and over the succeeding 6 minutes the mass moved downstream until it 
rested in the throat at 13 minutes.  Flow was not detected at 12.5 minutes, although from 
visual observation of the images it seemed that a very small channel remained patent until 
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13.5 minutes or even later.  Histological examination of the thrombus removed from this 
experiment showed that a long propagating tail of fibrin and platelets grew from the 
downstream end of the occluding thrombus.  Additionally, a packet of primarily red 
blood cells was connected between the occluding thrombus and the propagating tail.  The 
shear rate based on average flow rate for the first 7.25 minutes was 40,900/s.  
 
 
Figure 39.  Thrombus formation image sequence in the 93% stenosis at time = 0.  The 
lumen diameter was approximately 430 µm.  Flow was from right to left.  Magnified at 
1.6x.  Filename:  93per_sten_E_12sec_1-24-39_2fps.mov (1.17 MB). 
 
 The image sequence in Figure 39 above started at the beginning of flow 
measurement (0 seconds) and continued until 6 minutes.  At 5 minutes, an embolus 
lodged in the throat which resulted in flow cessation.  Typically, emboli occurred within 
the first five minutes of flow.  Only rarely did an embolus or blood clot block flow 
upstream and the vast majority blocked at the throat of the stenosis whereas it was the 
least diameter by an order of magnitude or more. 
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 These image sequences can be compared to non-stenotic experiments and 
experiments that remained patent throughout the blood flow. 
 
 
Figure 40.  Thrombus formation image sequence in the 0% stenosis at time = 0.  The 
lumen diameter was approximately 1540 µm and the black marking on the bottom 
indicated that the surface to the left of that line was collagen coated.   
Flow was from right to left. Magnified at 1.6x.  Filename:  0per_sten_N_20sec_1-26-
20_2fps_C.mov (2.19 MB). 
 
 The image sequence in Figure 40 above started at the beginning of flow 
measurement (15 seconds) and continued until 10 minutes.  Although there was a slight 
change in shading, the thrombus deposited was not significant enough to be visualized.   
 
Platelet Deposition Based on Thrombus Formation Images 
 For the three experiments that led to complete occlusion and had thrombus 
formation images, platelet deposition was calculated based on the composition of the 
thrombus, the geometry of the visible area, and a count of the number of pixels over a 
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certain grayscale threshold in each image.  Because of the opaque nature of blood, 
thrombosis was only visible in a limited area of the two dimensional image.  But in that 
visible area, thrombus could be identified by pixels that had a grayscale value greater 
than a specified threshold.   
 In order to compare the change in pixels, test sections and other equipment should 
not move and light intensity should not be adjusted.  Typically, thrombus formation was 
not evident for the first few minutes and any necessary adjustments were made in that 
time.  Platelet deposition was determined for a respective image in seven consecutive 
steps. 
 
1-Designation of the Mask 
 The first image that had subsequent images with (a) the test section in the same 
position and (b) the same background light intensity was called the mask.  The number of 
pixels over the threshold in this mask image was subtracted from the subsequent images 
in order to compare the changes in the number of threshold pixels.  Therefore, the image 
used for a mask was the baseline in the number of pixels over the threshold.  In most 
experiments, this was the first or second image and zero thrombus formation was 
assumed for the mask.  Changes in light intensity and position were recorded during 
experimentation in the lab notebook, although in some cases slight changes in the 
position of the test section occurred as a result of flow in the oil-immersion bath.  A 
single movement in the middle of the experiment was accounted for by establishing a 
second mask for the next applicable image and correcting for any change in the number 
of pixels.   
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2-Isolation of the Region of Interest 
 In order to clean up the images, a region of interest around the lumen of the test 
section was isolated.  A black background was applied above and below the region of 
interest using Adobe Photoshop 6.0.  To expedite the process, an action was created with 
the mask that made a black layer around the region of interest, and then the action was 
batched for all of the subsequent images.   
 
3-Choice of a Grayscale Threshold Value 
 This was an important step in order to correlate the number of pixels greater than 
the threshold with the amount of thrombus present at the time of a particular image.  For 
the platelet deposition calculation in this analysis, Otsu’s method was used to designate 
the threshold for all the images processed.  8-bit TIFF grayscale images with 1280 × 
1023 dimensions had pixel values between 0 and 255, where 255 identified a white pixel.  
In order to convert this image to binary black and white, a threshold grayscale value was 
selected so that pixels equal to or above that threshold will be converted to white pixels.  
For experiments that led to complete occlusion, it was clear that thrombus attached to the 
wall or embolus trapped in the throat was translucent and was displayed with lots of 
white pixels.  But for experiments that remained patent and did not have gross thrombus 
formation this was difficult to assess.  Figure 41 below has shown an example of an 
image that exhibited thrombus formation but needed a threshold between 0 and 255 in 





Figure 41.  This is an example of grayscale image that exhibits thrombus after 10 
minutes in an 85% stenosis.  Some loss of quality occurred during compression for this 
figure. 
 
 Based on the image in Figure 41, a histogram of the grayscale pixels in Figure 42 
below describes the distribution of pixels.  By assigning a threshold too low, pixels in the 






Figure 42.  Distribution of grayscale pixels for corresponding image in Figure 41.  
Majority are either 0 (black) or 255 (white) and blend into the axis.  The remainder is 
distributed especially between 25 and 100.  Total number of pixels is 1280 × 1023. 
 
As the experiment continued, a large number of pixels, approximately 100,000 shift 
towards 255.   
 
 
Figure 43.  This is an example of a black and white image after conversion from 
grayscale image in Figure 10 using level as 0.25, or 64 on a grayscale. 
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 Figure 43 does not accurately depict the formation of thrombus because at a low 
grayscale value, the amount of thrombus is overestimated.  Conversely, designation of 
the threshold level as 0.75 produced a black and white image where the lumen remained 
black as if thrombosis had not occurred.  Figure 44 below designated the threshold level 
as 0.5 corresponding to 128 on the grayscale.  This threshold as well as Otsu’s method 
represents the formation of thrombus well.  Otsu’s method chooses the threshold to 
minimize the interclass variance of the thresholded black and white pixels. 
 
 
Figure 44.  This is an example of a black and white image after conversion from 
grayscale image in Figure 41 using level as 0.5, or 128 on a grayscale.  Thrombus on the 
walls can be identified and accounted for at this threshold. 
 
 For various thresholds, the number of pixels over the threshold illustrated much 
the same trend for experiments that led to complete thrombotic occlusion.  Figure 45 
below demonstrates that the number of grayscale pixels converted to white pixels is 
similar for each of the threshold methods, although the maximum number does vary.  
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Figure 45 uses multiple threshold levels for each image taken during the experiment 






















Figure 45.  Various threshold levels illustrate a similar trend for an experiment that led to 
complete thrombotic occlusion, although Otsu’s method and a fixed 0.5 level reach the 
highest number.  Each image was reduced by the number of white pixels in the mask at 0. 
 
 For experiments that remain patent but have some thrombus formation, a low 
threshold could be used to correlate the number of pixels to thrombus deposited. Whereas 
this method was used on experiments that led to complete occlusion, the white pixels 
were unmistakably thrombus and completely filled the visible area.  
 
4-Conversion of the Image to Black and White 
 After the threshold was designated, images were converted to black and white 
images quickly in Matlab using the ‘im2BW’ function.  The code for applying Steps 3, 4, 
and 5 is in Appendix A-1.  
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5-Count of the Number of Pixels over the Threshold 
 Two ‘for’ loops were used to go through the matrix of the binary data that makes 
up the black and white image.  The count was reported for each image and represented 
the number of white pixels at the time the image was taken.  A specific code was written 
for each mask and its subsequent series of images.  The code and the specific parameters 
for each experiment are in Appendix A-1.   
 
6-Normalize Subsequent Images by the Count of the Mask 
 The mask was used to reduce the number of white pixels from subsequent images 
that were processed in the same manner.  Therefore the number of pixels representing 
thrombosis started at zero. 
 
7-Scale the Count of White Pixels by a Platelet Deposition Factor 
 For each white pixel counted, the number of platelets was estimated.  Platelet 
deposition was calculated based on histological analysis of the composition of an 
occluding thrombus, the dimensions of thrombus visible in each image, and the number 
of white pixels counted for each image.  Each image is a two dimensional representation 
of a three dimensional conic section.  Therefore for each pixel in the visible area of the 
image, a scale was used to estimate the volume of thrombus represented the single pixel.  
The following assumptions were made: 
• The occluding thrombus is cylindrically shaped with a diameter of the least throat 
diameter and a length defined by the visible length at the time of flow cessation 
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• At the time of flow cessation, thrombus completely fills the geometry of the 
visible area 
• The growth of thrombus volume from zero volume at time zero until full size 
thrombus at the time of flow cessation is linear  
• The growth of thrombus volume has the same slope as the increase over time of 
the number of pixels greater than the threshold 
 
 The length and width of the visible area was determined from image analysis.  
The width was always approximated by the inner diameter at the throat and the length 
was calculated by measuring the distance between the borders of the visible area which is 





Figure 46.  Outline of the visible area at the time of total occlusion (16.5 minutes).  
Length determined to be 2.5 mm.  The throat diameter was 610 µm.  The visible area in 
this example was 1.48 mm2.  Same 85% stenosis as in previous steps. 
 
 The number of pixels in the visible area was similar to the total number of pixels 
that were counted at the time of flow cessation.  The total number for this example is 
approximately 100,000 based on the value at 16.5 minutes in Figure 46 above.  Platelet 
deposition (PD) was determined with Equation 12 and for this example was 1.13 billion 
platelets/cm2 based on 100,000 pixels over the threshold and 537 platelets per pixel 
conversion. 




## ××=    Equation 12 
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where the number (#) of pixels is the value obtained from Step 6, SA is the surface area of 
the cylinder, calculated by π × D × L, and the number of platelets per pixel conversion is 
determined by Equation 13: 
 
    
MPV
Vfplatelets thrombus×=#    Equation 13 
 
where f is the proportion of platelets in a thrombus, Vthrombus is the volume of the 
thrombus in the visible area, and MPV is the mean platelet volume for the particular 
blood sample, approximately 8.6 femtoliters.  The thrombus volume is calculated by the 
equation of a cylinder: π × D2 × L/4.  The difference between Equation 10 and Equation 
13 is that the volume of thrombus in Equation 13 is that which exists in the visible area 
only.  The conversion of the number of platelets per pixel was used as a scaling constant 






























Figure 47.  85% stenosis.  Platelet deposition based on analysis of the image sequence in 
Figure 36.  Time of flow cessation was at 16.5 minutes.  Experiment 12.15.9. 
 
 Platelet deposition in Figure 47 shows that platelet deposition is negligible before 
10 minutes when it begins an acute deposition phase that does not terminate until after 
flow cessation.  Platelet deposition after the time of flow cessation in this model, 16.5 
minutes in Figure 36, should not be evaluated because separation in the glass tubes distal 











































Figure 48.  Reproduction of Figure 47 with a logarithmic scale for platelet deposition.  
Platelet deposition increased to the order of millions within the first five minutes and then 
slowly increased until the acute phase began around 12 minutes.  Negative values were 
omitted. 
 
 An acute deposition rate constant was determined by fitting a line to the data 
between 12 and 16.5 minutes in Figure 47.  The slope of this line is the acute deposition 
































Figure 49.  96% stenosis.  Platelet deposition based on analysis of the image sequence in 
Figure 38.  Time of flow cessation was at 13.5 minutes.  Experiment 12.15.33. 
 
 The errors for these values are on the order of 100 million platelets/cm2, therefore 
the fluctuation and negative values before 10 minutes are understandable.  The important 
value is the rate of acute deposition which was found for the time between 11 and 13.5 
minutes to be 5 × 106 platelets/cm2/s. 
 In one experiment, shown in Figure 50 below, movement of the test section 
inhibited the continuous analysis of platelet deposition.  Movement of the test sections 
was due to surface tension in the glycerin bath pulling the test section in one direction.  































Figure 50.  85% stenosis.  Platelet deposition based on analysis of the image sequence in 
Figure 37.  Time of flow cessation was at 17.5 minutes.  Experiment 12.8.9. 
 
 The acute rate of platelet deposition was calculated between 11 and 13.5 minutes 
to be 1.7 × 106 platelets/cm2/s.   
 
Rate of Platelet Deposition under High Shear Rates 
 The rate of platelet deposition increased with shear rate using the acute rate as a 
comparable between experiments.  Both platelet deposition models were used to compare 
the effect of high shear rates.  There was good agreement between the models for 2 out of 










































Linear (Flow Rate Model)
 
Figure 51.  Both platelet deposition models showed that the acute rate of platelet 
deposition increased with shear rate.  Plot included all 7 experiments that led to complete 
thrombotic occlusion, where 3 had analysis from both models.  This data has also been 
presented in Table 4 below. 
 
 For the flow rate model, the rate of acute platelet deposition for each experiment 
increased with shear rate until 42,000 s-1.  The rate of platelet deposition was between 1.1 
and 3.6 million platelets/cm2/s.  Only three experiments had image analysis, so at these 
initial shear rates, the acute rate of platelet deposition was compared.  They are on the 









Table 4.  The acute rates of platelet deposition for each platelet deposition model. 
Percent 
Stenosis 




















Rate of PD 
(x106 
plts/cm2/s) 
85 12.8.1.9 17.5 11,500 135 1.67 1.88 1.7 
85 12.15.2.9 17.5 10,000 129 1.1 1.25 5 
Avg ± 




4 1.39 ± 0.40 1.57 ± 0.45 
3.35 ±  
2.33 
95 10.27.4.7 16.5 24,200 118 1.88 0.9   
96 11.3.3.33 10 32,700 96 2.4 1.95   
96 11.22.4.33 18 42,100 129 3.08 1.57   
96 12.1.2.33 13 42,200 138 2.37 2.03   
96 12.15.2.33 13.5 40,900 136 3.6 1.38 5 
Avg ± 




± 17.2 2.67 ± 0.67 1.57 ± 0.46   
 
 In summary, in the higher shear regime of ≥ 95% stenosis by area, under an 
average initial shear rate of 36,420 ± 7,890 s-1 platelets deposited at an acute rate of 2.67 
± 0.67 million platelets/cm2/s as opposed to only 1.39 ± 0.40 million platelets/cm2/s 
under a lower average initial shear rate of 10,750 ± 1,060 s-1.  The p-value for the 
comparison of acute rate was p < 0.054 using a two tailed t-Test.  The average time of 
flow cessation was greater for the 85% stenosis at 17.5 ± 0.0 minutes in comparison to 






Histology and Composition Analysis 
Five samples that caused blockage as a result of thrombotic occlusion were 
chosen for histological examination, as well as one embolus and some other various 
thrombi.  A list of the samples and their status has been presented in Table 5 below.   
 
Table 5.  Status of Histological Samples. 
TYPE SAMPLE DESCRIPTION EMBEDDING STAINED 
Occluding 
Thrombus 11.8.1.33 Thrombus; 1-1.2 mm length originally Longitudinal NO 
  11.22.4.33a Thrombus and propagating tail;  Longitudinal CARSTAIRS 
  11.22.4.33b red clot found on the propagating tail Longitudinal CARSTAIRS/vWF 
  12.1.2.33 
Thrombus; 1-1.2 mm length originally, 
sample tore in half before processing X-SEC CARSTAIRS/vWF 
  12.8.1.9 
Thrombus; downstream end of clot is 
the bottom end of section on the slide Longitudinal CARSTAIRS/vWF 
  12.15.2.33 
Thrombus connected to tail and red 
packet Longitudinal CARSTAIRS/vWF  
         
Emboli 11.17.2.7 Embolus found X-SEC CARSTAIRS 
         
Other 11.10.3.33 Thrombus on leading edge X-SEC NO 
  11.17.2.33 Thrombus found on converging side Longitudinal CARSTAIRS 
  12.8.1.39 Thrombus and possible embolus united X-SEC CARSTAIRS 
Control COAG Coagulated Porcine Blood X-SEC   
 
 Other completely occlusive thrombi included 12.15.2.9 which was lost while 
removing it and 10.27.4.7 and 11.3.3.33 which were not saved for histological 
examination.  11.8.1.33 formed from thrombotic occlusion, although it had a non-steady 
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control and was exempt from analysis on this condition.  11.22.4.33 was split into two 
sections for embedding although they came from the same side of the occluding 
thrombus.   
 Table 6 lists the blood species and their respective characteristics after Carstairs 
staining. 
 
Table 6.  Appearance of Blood Species after Carstairs Staining. 
Species Appearance 
Red Blood Cells (RBCs) red or orange, large discoid cells (7-8 µm) 
White Blood Cells Purple, large spherical cells (~10 µm) 
Platelets Blue, small cell fragments (2-4 µm) 
Fibrin Purple or pink strands 
 
 In order to detect vWF, an anti-human vWF primary antibody was also used in an 
alkaline phosphatase detection system for immunohistochemistry.  Secondary antibody 
was a biotintylated goat anti-rabbit.  A red marker was matched to the secondary 
antibody and a background hematoxylin counter-stain was used to identify the remainder 
of the thrombus. 
 Dense packets of platelets were identified which may have been the dense areas 
described as striations during the experiment.  The perimeter of the clots has a significant 





Figure 52.  4x magnification.  Control.  Porcine pig blood that had heparin anticoagulant 









Figure 54.  4x magnification.  Control.  vWF antibody with a vector red stain and 
background with a hematoxylin counter-stain.   
 
 Von Willebrand Factor is present in the control coagulated porcine sample, 







Figure 55.  Sample 12.8.1.9.  85% stenosis.  Occluding thrombus was composed 
primarily of platelets and fibrin.  Original length was measured as 6 mm.  After 
processing it shrunk to 4.8 mm as has been presented.  Average width was about 0.4 mm.  
The inner diameter of the stenosis throat was 0.61 mm.  Upstream end was fibrin rich and 
downstream end was bulky with RBCs trapped in rows.  Multiple images were 
photographed at 10x and then photostiched together. 
 
 
Figure 56.  Sample 12.8.1.9.  85% stenosis.  vWF antibody used with red stain indicates 
that vWF is present in the occluding thrombus.  Cross section taken approximately 200 






Figure 57.  Sample 12.8.1.9.  10x magnification.  Fibrin layer was evident not only on 
the perimeter but has also formed centrally in lines parallel with the axis.  Scattered 
WBCs could be identified by their circular shape.  The parallel lines on the lower end of 
image were artifacts of sectioning. 
   
 The relative percentage of platelets was determined from Figure 55 of sample 
12.8.1.9.  The percentage of platelets, WBCs, RBCs, and fibrin was 81%, 1%, 1%, and 
17%.  Images were taken on a Nikon E600 microscope at 10x magnification.  The images 







Figure 58.  Sample 12.8.1.9.  10x magnification.  vWF was present in regions of platelets 
and has varying density. 
 
 
Figure 59.  Sample 11.22.4.33.  Occluding thrombus is on the left and a propagating tail 
of thrombus was identified as primarily RBCs and fibrin.  Photostitched image at 4x 
magnification.  The box shows the zone that has been magnified in Figure 60 below 









Figure 60.  Sample 11.22.4.33.  Occluding thrombus.  10x magnification.  Thrombus was 
heavily composed of platelets and lines of fibrin.  There were platelet dense regions and 
the most dense regions exist where blue was most intense.  The clot was not connected 
because either (1) this longitudinal cross section was at the throat of the stenosis but it 
was not in the center of the lumen, or (2) it was cleaved during processing.  The clot on 




Figure 61.  Sample 11.22.4.33.  Occluding thrombus.  40x magnification.  The clot has 
varying densities of platelets as was observed from the intensity of blue shade.  Only a 







Figure 62.  Sample 11.22.4.33.  vWF present in thrombus.  Four images photostitched as 
in Figure 59 above. 
 
 In this next sample, a fibrin tail formed distal to a 96% stenosis.  The thrombus in 
this experiment migrated or rolled from the converging section into the throat of the 
stenosis, visible in the movie discussed earlier.  The thrombus is visible at the back end of 
the occluding thrombus featured in Figure 63 below.  It has a high platelet concentration 
but is not as long as the previous examples.  The connections between each of the 
sections are highlighted because the species in that connection were under extreme 
stresses.  The connection from the occluding thrombus to the RBC packet was probably 
under high stress during formation.  The connection to the fibrin tail may have been 
under relatively less stress as a result of the low-shear expansion region.  It was unknown 










Figure 63.  Sample 12.15.2.33.  Images taken at 4x and photostitched together.  Distal to 
the occluding thrombus is a large packet of fibrin and RBCs with some strings of 
platelets.  Distal to the connection between the thrombus and the packet is a propagating 
tail of 9 mm length.  After processing and histology it shrunk to approximately 5.7 mm.  
The tail can be seen in Figures 68 and 69 below. 
 
 
Figure 64.  Sample 12.15.2.33.  Occluding thrombus.  Images taken at 10x and 
photostitched together.  The composition is primarily platelets, although in the center 
there is a large deposit of RBCs which is surrounded by fibrin.  The connection to the 





Figure 65.  Sample 12.15.2.33.  Occluding thrombus with vWF marker.  Images taken at 
4x and photostitched together.   
 
 
Figure 66.  Sample 12.15.2.33.  Connection between occluding thrombus and RBC 
packet. 10x magnification.  Some large deposits of platelet rich thrombus and a few 





Figure 67.  Sample 12.15.2.33.  RBC packet. 4x magnification.  Fibrin clearly on the 
perimeter and a one layer deeper is a dense RBC region.  Platelets are mostly at the top 






Figure 68.  Sample 12.15.2.33.  Fibrin tail.  Primarily fibrin with some platelets.  4x 








Figure 69.  Sample 12.15.2.33.  This is a segment of the fibrin tail which was primarily 
fibrin with some platelets and WBCs visible.  The tail was one continuous sheet although 
when sectioned it only showing the folds which are the curves visible in the figure.  10x 





Figure 70.  Sample 12.15.2.33.  vWF is present in the propagating tail.   
 
 Thrombus formed in the stenosis was difficult to remove during cleaning whereas 
removal of embolus was very easy. 
 
Fibrin Tail Propagation  
Histological data demonstrate that the propagating tail in sample 12.15.2.33 was 
constituted primarily of fibrin with smaller amounts of platelets and WBCs.  vWF has 
also been identified, and may be in conjunction with platelets or present as a plasma 
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protein.  This was the single experiment where a fibrin tail was identified and therefore 
the occurrence was 1 out of 7 cases which led to complete occlusion.  From thrombus 
formation images taken during the formation of the occluding thrombus, it is evident that 
only a small channel was patent on the side of the stenosis throat before total occlusion.  
Therefore the shear forces in the channel may have been enormous and the region distal 
had flow separation and regions of high residence time.  The propagation of the tail was 




















RESULTS: DETACHMENT STRENGTH OF THROMBUS 
 
 The force required to detach the thrombus was estimated based on the maximum 
upstream pressure measured before removal.  Thrombus removal was attempted in 4 out 
of the 7 cases of complete thrombotic occlusion.  Based on results from 1 out of the 4 
experiments that met the necessary criterion, the detachment force of the thrombus was 
approximately 9 milli-Newtons.  Emboli were also removed in order to compare the 
maximum pressure required to remove an attached thrombus rather than a particle that 
occluded flow.   
 The thrombus was completely removed from the throat region in 3 out of 4 
thrombus removal experiments.  Thrombi covered primarily the converging, throat, and 
diverging sections of the stenosis and tended to stay united in one body, although some 
areas of the thrombus were denser than others.  In the single removal experiment that did 
not detach in one body, a channel of blood flow formed in the thrombus and the thrombus 
did not detach from the wall. 
 The attachment of the thrombus was affected by stasis and the duration of time 
between the formation of the clot and the removal.  Thrombus detached from the wall in 
two experiments where the removal experiment was completed 100 minutes or later from 
the occasion of thrombotic occlusion.  Although in flow platelets aggregated and the 
thrombus firmly attached to the surface, in stasis thrombus detached from the wall.  Table 
7 below identifies the approximate duration of time between the time of flow cessation 
and the time of thrombus/embolus removal. 
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(mmHg) Experiment TO/E 
Did the 
Thrombus/Embolus 
Remove in One 
Piece? 
1 40 438 12.1.2.33 TO Yes 
  30 - 12.1.2.7 E Yes 
2 90 66 12.8.1.9 TO No 
  75 - 12.8.1.39 E Yes 
3 100 182 12.15.2.9 TO Yes 
4 170 730 12.15.2.33 TO Yes 
  75 382 12.15.2.39 E Yes 
 
 The four thrombus removal experiments are numbered 1 though 4 and designated 
Thrombotic Occlusion (TO) as opposed to Embolus (E).  The maximum upstream 
pressures recorded at the time of thrombus removal has also been presented in Table 7 
although only the 1st experiment was applicable for analysis of thrombus detachment 
strength because of the criterion listed below. 
 
Detachment Strength of Thrombus 
 The force that acted on the thrombus at the time of detachment was calculated 
based on the maximum upstream pressure before removal.  This analysis was done for 
removal experiments where the following conditions applied: (A) the thrombus remained 
adherent to the surface of the stenosis until removal, and (B) the thrombus dislodged 
completely from the throat.  The only experiment in this work that met these conditions 
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was experiment 12.1.2.33, described below.  Since only one data point was available, the 
calculation was an order of magnitude approximation. 
 The maximum upstream pressure at removal for this experiment was 438 mmHg.  
The maximum force at the time of removal was calculated using Equation 14. 
 
    APF ×= maxmax    Equation 14 
 
where the maximum force (Fmax) on the thrombus at the time of detachment was the 
product of the maximum pressure (Pmax) at that time and the cross-sectional area (A) at 
the widest part of the thrombus.  The widest part of the thrombus was determined from 
dimensions measured from images taken after the removal.  The maximum pressure acted 
on the area of π × D2 / 4, where D was the greatest width of the thrombus.  For the 
thrombus in this experiment the max width of the thrombus, D, was 0.44 mm therefore 
the maximum pressure of 438 mmHg acted over 0.15 mm2 which produced a force on the 
thrombus of 8.9 milli-Newtons (mN).  The thrombus was assumed to be a rigid body and 
the cross section of the thrombus of the surface between the blood and the clot was 
assumed to be circular.   
 
Thrombus Removal Experiments 
 Removal of thrombi was attempted on 4 completely occlusive thrombi and the 
maximum pressures reached were between 66 and 730 mmHg.  Each of the removal 
experiments of the four thrombotic occlusions as well as one embolus removal 
experiment has been described below. 
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1. Experiment 12.1.2.33 
 In this experiment, the thrombus was attached to the surface of the stenosis and it 
was removed completely.  Images taken before and after illustrate that the thrombus was 
attached throughout the throat of the stenosis, that it moved downstream after removal, 
and that only a minor layer of thrombus remained after removal. 
 
 
Figure 71.  Image of occluding thrombus before removal.  Blood separated on the 
downstream side due to stasis.  Flow was from left to right.  2x magnification.  Throat 
diameter is 310 µm in this 96% stenosis. 
 
 
Figure 72.  Higher magnification on apex of stenosis.  Image of occluding thrombus 
before removal.  Striations were visible and the clot was exposed due to the clear plasma 
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on the sides.  Thrombus was attached to the walls.  Flow was from left to right.  4x 
magnification.  Throat diameter was 310 µm in this 96% stenosis. 
  
 
Figure 73.  Thrombus was attached to the walls.  Higher magnification on apex of 
stenosis before thrombus removal.  10x magnification.   
 
 For this experiment, blood was drawn at 8.30 am and the clot was formed by 
12.07 pm.  The images in Figures 71 to 73 were taken approximately 20 minutes later.  
Thrombus removal experiments began at 12.45 pm, within an hour of the thrombus 
formation.  The images taken after removal in Figures 75 and 76 below were taken at 2 
pm.   
 It was evident from visual observation during the experiment that the thrombus 
was almost one complete body when it detached.  Figure 74 shows the rise of upstream 

































Figure 74.  Upstream pressure reached a maximum around 450-500 mmHg.  The data 
acquisition system recorded only one half of a cycle, therefore data measurement missed 
the peak.  Gaps in data were filled in by interpolation.  Experiment 12.1.33. 
 
 Based on the raw data alone, the upstream pressure reached a maximum at 438 
mmHg.  Interpolation of the last and first data points provided an estimate of a 
continuous pressure curve.  This was a conservative underestimate within 10 mmHg ( ~ 
2.5 %) of the pressure that the thrombus was removed because the interpolation was 
made from the greatest pressure recorded to the next measurement which was only 9 
mmHg.  Images taken after the removal showed that the thrombus was completely 





Figure 75.  The downstream side of the stenosis.  The thrombus was seen laying in the 
lumen and remained attached to the wall (indicated with green arrows) near the edge of 
the diverging segment.  2x magnification.  The downstream inner diameter was 
approximately 1.62 mm. 
 
 
Figure 76.  The apex of the stenosis showed a small amount of thrombus (indicated with 
arrows) still attached to the wall of the stenosis.  Throat diameter was 310 µm. 10x 
magnification. 
  
 There was some remaining thrombus in the stenosis after removal as shown in 
Figure 76 above.  The occluding thrombus was detached from this mural thrombus on the 
inner surface and left the lumen of the stenosis covered with a thin layer of visible 
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thrombus.  Therefore the thrombus and collagen were not stripped off of the smooth glass 
surface together in this experiment.  Collagen on the glass surface alone was not visible.  
This indicates that the weakest bond was platelet to platelet, not platelet to collagen or 
collagen to glass. 
 
2. Experiment 12.8.1.9   
 In this experiment, the thrombus was attached throughout the stenosis throat but 
did not detach in one complete body.  Pressure build up of around 60 mmHg was relieved 
by the formation of a channel of blood flow.  The maximum pressure recorded was 66 
mmHg as shown in Figure 78. 
 
 
Figure 77.  Image of the occluding thrombus before removal.  The occluding thrombus 
was attached throughout the throat and was primarily white thrombus although it had 


































Figure 78.  Upstream pressure reached a maximum around 66 mmHg.  From visual 
observation, a channel opened through the center of the thrombus which relieved pressure 
but the thrombus did not detach from the walls.  Interpolation of the last and first data 
points provided an estimate of a continuous pressure curve.  Experiment 12.8.1.9. 
 
 After the removal experiment, the thrombus was still attached to the throat and 
was forced out with a pipette and formalin.  The thrombus reversed directions as seen in 
Figure 79, but also remained attached to the glass tube at the region between the 
diverging and downstream sections.  The thrombus was removed with some difficulty by 





Figure 79.  Image of the occluding thrombus after removal experiment and manual 
removal from throat.  View of downstream side of stenosis.  The occluding thrombus 
reversed direction and remained attached to a thrombus at the edge of the diverging and 




Figure 80.  Magnification of the attached area in Figure 79.  The occluding thrombus 
reversed direction and remained attached to a thrombus at the edge of the diverging and 






3. Experiment 12.15.2.9   
 In this experiment, thrombus was not completely attached to the walls of the 




Figure 81.  Upstream end of stenosis showed occluding thrombus before removal.  
Throat diameter was 610 µm.  2x magnification. 
 
 
Figure 82.  Throat of stenosis showed occluding thrombus before removal.  The clot 
separated from the walls at the locations indicated with arrows.  Throat diameter was 610 





Figure 83.  The clot separated from the walls at the locations indicated with arrows.  The 
thrombus was non-homogeneous and had greater density in certain areas.  Throat 



































Figure 84.  Upstream pressure reached a maximum around 182 mmHg.  Interpolation of 
the last and first data points provided an estimate of a continuous pressure curve.  
Experiment 12.15.2.9. 
 
 The maximum upstream pressure was recorded correctly at 182 mmHg.  This 
relatively low pressure may have been a result of the decreased surface area of 
attachment shown in Figures 13 and 14 prior to the thrombus removal experiment.  
Photographs of the test sections after this experiment were not taken. 
 
4. Experiment 12.15.2.33 
 In this experiment the thrombus was fully detached from the wall and when 
pressure was applied, it squeezed through the throat and moved downstream as one 
complete body.  In this experiment the time between the formation of thrombotic 
occlusion and the removal experiment was 170 minutes, the longest interval of these 






Figure 85.  Image of the occluding thrombus before removal.  The thrombus detached 
from the wall and the bulk of the occluding thrombus (identified with arrow) shifted into 
































Figure 86.  Upstream pressure could not be measured at the maximum pressure for 
removal because of a voltage threshold (590 mmHg) although it may have reached a 
maximum around 730 mmHg.  Interpolation of the last and first data points provided an 
estimate of a continuous pressure curve and an extension based on the last pieces of data 
estimated the maximum pressure.  Experiment 12.15.2.33. 
 
 The bulk of the occluding thrombus rested in the converging section, as seen in 
Figure 85 above, until pressure was applied and the thrombus moved into the throat and 
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was squeezed through the throat.  From visual observation during the removal 
experiment, this occurred within the first moments of the experiment.   
 The data acquisition system had a voltage threshold at 5 Volts.  To compensate 
for this, the pressure transducer was zeroed at -163 mmHg to provide more range.  In this 
experiment, the maximum pressure to remove the thrombus was greater than the 
threshold and therefore the data had a plateau at 590 mmHg.  The maximum pressure was 
estimated as 730 mmHg by generation of an extension line (y = 51.908x - 365.41) based 
on the last segment of data and assignment of a cutoff at 21.1 seconds which was the last 
recorded data point of the plateau.  Photographs of the test sections after this experiment 
were not taken. 
 
Embolus 
 Three emboli were also forced through the throat at the site of blockage using the 
thrombus removal protocol.  The dimensions of the emboli were unknown.  In the 
following embolus experiment, the embolus was not attached to the walls and was forced 







Figure 87.  Image of the embolus stuck in converging section of throat before removal.  
The appearance was not unlike that of the thrombus, but the immediate pressure rise of 4 
mmHg at flow cessation and the sudden appearance in the thrombus formation video 
indicated that it was a thrombus.  Throat diameter was 430 µm in this 93% stenosis. 2x 































Figure 88.  Upstream pressure reached a maximum around 382 mmHg.  Interpolation of 
the last and first data points provided an estimate of a continuous pressure curve.  
Experiment 12.15.2.39. 
 
 The pressure curve for the embolus was very similar to the other experiments and 







 A method to optically record thrombosis and occlusion of whole blood flowing 
through high grade hour-glass-shaped stenoses has been presented.  Thrombus formed on 
collagen-coated walls of the stenosis region in this in vitro model has been visualized by 
light scattering from whole porcine blood flow under high shear.  Total occlusion at the 
throat of the stenosis has been achieved with reproducible conditions and video, flow, 
and histological recordings. 
 This work has shown that the rate of platelet deposition on collagen increases 
until 40,000 s-1 and that platelets sustain accumulation even at these very high shear rates. 
In comparison to similar thrombosis studies on collagen, this follows the trend and 
predicts that the growth of thrombus increases even at these high shear rates. 
 The 85% stenosis by area (~61% stenosis by diameter) is mildly stenotic, yet in 
this work it led to thrombotic occlusion in a time similar to the 96% stenosis.  Stenosis 
below 75% by diameter is considered to be moderate yet it is associated with sudden 
cardiac death.  Therefore this model may be useful in learning more about the 
mechanisms in acute thrombosis and may be used in future studies that quantify the 
adhesion strength per platelet in this high shear regime. 
 The thrombus in this work was detached at a maximum upstream pressure of 
~450 mmHg, which is six-tenths of an atmosphere, or roughly 4 times mean arterial 
blood pressure.  The total thrombus detachment strength was calculated to be 
approximately 8.9 mN.  In this chapter, the adhesion strength of a platelet on the 
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periphery of the thrombus has been estimated to be on the order of 30 nN based on the 
thrombus removal data.  This is consistent with the in vitro measurements of glycoprotein 
surface density and adhesion strength found in literature review.  This number can be 
used to estimate the bond strength of single glycoproteins. 
 
In Vitro Model of Occlusive Thrombosis 
 In the flow system presented in this work, stenosis equal to or greater than 65% 
by area reduced flow.  Autoregulation which occurs in vivo, when the downstream 
vessels dilate in order to provide greater flow distal to the stenosis, would be expected to 
maintain an unreduced flow until the percent stenosis may be greater than 65%.    
 Experiments in this model were conducted at room temperature which is lower 
than body temperature.  The viscosity of the blood as well as the kinetics of blood 
constituents may be affected by the lower temperature.  Experiments could be more like 
body temperature, 37°C, by submerging the platelet transfer bag in an isothermal bath. 
 
Formation of Completely Occlusive Thrombus 
 In ex vivo and in vitro models that do not achieve complete occlusion, the possible 
causes may include short exposure duration or depressed platelet deposition from 
anticoagulant.  This model achieved total occlusion in 7 experiments, roughly 25% of the 
total number of severely stenotic test sections tested.  This model shows that maximum 
platelet deposition occurs at the throat as described by the Badimon et. al.[41] and 
Markou et. al. [42] experiments. 
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 The observations of completely occlusive thrombus in these experiments were the 
platelet dense regions in the thrombus, the concentric striations of thrombus in the throat 
region, flow cessation by visual and flow measurement, and the ability to form a 
propagating fibrin string under high shear stress. 
 In the thrombus formation video of the 96% stenosis a thrombus may have 
migrated into the throat of the stenosis.  The white pixels in these images identify 
thrombus development on the walls and at first a significant thrombus forms in the 
converging region, which corresponds to the location of peak shear rate.  This thrombus 
may have migrated into the throat because the white pixels in the initial location return to 
gray and a group of white pixels slowly shift towards the throat in each time lapse.  Once 
in the throat, the number of white pixels increased until total occlusion. 
 After formation of totally occlusive thrombus, thrombus was observed to become 
compact and detach from the walls of the stenosis.  The strength of bonds within the 
thrombus may be stronger than those between collagen and thrombus because with time 
the thrombus pulled away from the wall and became more compact.   
 Angiographic data in patients suffering from acute myocardial infarction 
demonstrated total occlusion and demonstrated that much intracoronary thrombus may 
form distal to the occlusion [68].  The incidence of certain angiographic features in this 
study such as cutoff pattern of occlusion, accumulated thrombus (>5 mm) proximal to the 
occlusion, and floating thrombus all indicated “high-burden thrombus formation” and 
were used as predictors of slow-flow and no-reflow phenomenon. 
 The model of platelet deposition using images correlated well with the model 
platelet deposition based on flow rate measurements.  The image calculations basically 
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used a threshold around 0.5 or 128 grayscale in order to define thrombus and was 
sensitive enough to detect thrombus growth continuously.  The flow rate model can be 
argued to be the more accurate representation of platelet deposition because thrombus 
formation was based on the increased resistance and the hydraulic diameter.  In 
comparison, the image analysis model was based on the light scattering of thrombus 
which may be high on the surface in view but not throughout the throat cross-section.  
The image analysis may have predicted a higher platelet deposition because of other 
contributions to light scattering such as blood separation.  If blood separated in the 
vicinity of the stenosis, then the translucent plasma would also be represented by the 
white pixels. 
 
Rate of Platelet Deposition versus Shear Rate 
 Thrombosis is clearly a function of shear rate and the rate of platelet deposition 
increases until beyond 40,000/s.  The acute phase of platelet deposition can be identified 
from continuous data and exists in thrombosis models by Markou et al.[42] and Badimon 
et. al.[41] and the experiments in this work.  The rate of acute phase platelet deposition is 
a good comparable across thrombosis models because in does not take into account the 
accelerating phase which may vary in length based on parameters of the model such as 
anticoagulation and blood source.  Figure 88 below identifies the upward trend of the rate 
of acute phase platelet deposition as a function of shear rate for the three models that 
have continuous platelet deposition measurements.  The flow rate model had a lower rate 
of acute platelet deposition than Badimon et al. and Markou et al., who used non-
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anticoagulated blood, potentially as a result of anticoagulation.  The blood sources of 
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Figure 89.  Acute rate of platelet deposition constants determined for each experiment 
that had continuous platelet deposition measurements.  Variation exists between the 
thrombosis models but the trend of increasing deposition rate as a result of higher shear 
rate is apparent. [41, 42, 44, 45] 
  
 Although the rate of platelet deposition decreased in the highest shear 
experiments for Barstad et al. [44], the experiments in this work demonstrate that platelet 
accumulation onto collagen still increases at an increasing rate until 40,000/s.  The 
Barstad et. al. experiments utilized an eccentric stenosis in a parallel plate chamber at 
Reynolds number 20.  This is not as physiologically relevant as the tube flow 
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Figure 90.  Platelet deposition onto collagen as a function of shear rate at 5 minutes of 
exposure time in comparison to Flannery acute rate platelet deposition based on flow rate.  
Platelet deposition rate at 5 minutes was calculated from platelet deposition data using a 
straight line method or differentiation from regression curves. [41, 42, 44, 45] 
 
 The rate of platelet deposition may vary remaining in the acute deposition phase 
until flow cessation or by decelerating and even decreasing to form a stable mural 
thrombus.  Both of these conditions occur in vivo and the thrombosis models discussed 
here may be used to determine if flow conditions affect this variation.  Thrombus 
formation onto collagen progressively increases and consistently led to complete 
occlusion at shear rates greater than 2,000/s by Markou et. al. and in some observed 







Thrombus Removal Experiments 
 Thrombi detached from the throat region in complete units in 3 out of 4 
experiments.  Often, an edge was seen in the throat region where thrombus had torn away 
from the layer that covered the tube.     
 After removal from the confines of throat, thrombus in these experiments 
proceeded to aggregate further and change dimension, therefore the thrombus must be 
fixed quickly.  Only the interactions with the wall were studied here because knowledge 
of the boundary conditions was known a priori.  Therefore experiments that did not 
detach from the wall but formed a channel at a location in the thrombus could not be 
analyzed.  Data indicated that thrombus removal experiments need to occur as soon as is 
possible from the time of total occlusion.  The time in between thrombotic occlusion and 
thrombus removal was important because as the blood next to the clot separated as a 
result of stasis, it may also have been possible that the integrity of the clot was 
susceptible to changes with time.   
 Adhesive forces may be strong between platelets because they aggregate and this 
may be the reason that the thrombus detached from the wall.  The concentric striations of 
platelet aggregates are very significant and demonstrated rapid growth until flow 
cessation.  Based on histological examination, the density of platelets is high in certain 
areas and it is this structure scaffolded by fibrin that caused flow cessation.  Dense 
aggregates pulled together after flow was terminated and it is possible that strong platelet 
bonds are also the reason for the thrombus detaching from the wall of the collagen coated 
stenosis.  The two thrombus removal experiments that detached from the surface before 
removal had a long duration between thrombotic occlusion and thrombus removal, 
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although since they both occurred on the same day, it is possible that the blood sample 
may have played a part. 
 Collagen as a substrate is useful to estimate the higher end of glycoprotein bond 
strength because it has been shown to yield irreversible platelet aggregation and the 
detachment strength is greater than for even vWF and fibrinogen substrates [52]. 
 Thrombi are typically removed in vivo through thrombolytic agents such as tPA 
described earlier or through mechanical removal of the thrombus or distal embolization 
protection devices or even laser ablation techniques [69].  The knowledge of platelet 
adhesion strength and platelet aggregation may be used to create anti-platelet therapies by 
weakening the bonds. 
 
Estimation of the Adhesive Strength of Platelets 
 Platelets attached and aggregated onto collagen Type I at initial shear rates 
between 10,000 s-1 and 40,000 s-1 in this in vitro model.  The adhesion strength of 
platelets was estimated in two ways by (1) a force balance using the measurement of 
maximum upstream pressure before thrombus removal, and (2) a force analysis based on 









Table 8.  Adhesion force estimates based on detachment and attachment strengths. 
 Detachment Method, Pmax Attachment Method, τ 
Force on Thrombus 8.9 mN 0.25 mN 
Force on Platelet 32 nN 0.89 nN 
 
 The detachment strength for the thrombus and the platelet was a factor of 36 times 
greater than the attachment strength.  Platelet adhesion strength was estimated for 
experiments where the occluding thrombus was (1) attached throughout the surface 
before removal, and (2) detached completely from the region of stenosis.  Only 1 out of 4 
experiments met these criteria, therefore these estimates of platelet adhesion strength are 
merely an approximation of the order of magnitude required for detachment/attachment 
of platelets.  
 
1. Platelet Detachment Strength based on Removal of Thrombus 
 The maximum upstream pressure at removal for the experiment described in 
Chapter V was 438 mmHg which produced a maximum force on the thrombus of 8.9 
milli-Newtons (mN).  The maximum force was equal to the sum of all the receptor-ligand 
bonds on the surface between the thrombus and the collagen, as in Equation 15.   
 









where the maximum force Fmax was equal to the sum of the adhesive forces for all the 
receptor-ligand (R-L) bonds for N adhesive molecules at the time of thrombus removal.   
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 The thrombus was assumed to be attached to the collagen surface by platelets 
alone therefore Equation 15 applied to receptor-ligand bonds between platelets and 
collagen or platelets and platelets.  This assumption was based on the high relative 
proportion of platelets in the occluding thrombus although it neglected potentially strong 
bonds from other species.  It may have been possible to use a composite analysis in order 
to evaluate the adhesive strength of multiple species such as platelets, fibrin, and vWF 
given knowledge of the density of those bonds and the relative contribution.  
 The surface that the platelets detached from was estimated based on the 





Figure 91.  Two-dimensional representation of thrombus in throat of stenosis.  The axis 
of the stenosis was left to right across the page. 
 
 In Figure 91, L was the length of the thrombus and D1 was the inner diameter at 
the stenosis throat.  The dimensions of the thrombus were approximated geometrically as 
two truncated cones joined together by the base with the smallest diameter.  The two-
dimensional side view has been shown in Figure 91.  For the thrombus in this experiment 
the max width of the thrombus, D2, was 0.44 mm.  The surface area between the 






















LDLDDSA π   Equation 16 
 
where the surface area (SA) of the model in Figure 91, not including the bases, was 
calculated from the reference dimensions in Figure 91.  Given the throat diameter of 
0.310 mm, the max width of the thrombus of 0.44 mm and the length of 1.3 mm, the 
surface area was calculated to be 1.54 mm2 between the thrombus and the collagen-
coated surface.   
 The number of platelets on the throat surface was estimated by Equation 17. 
 
    
MPA
SAfPlatelets p ×=#    Equation 17 
 
where the number of platelets was evaluated from the surface area (SA), the mean platelet 
area (MPA), and the proportion of platelets (fp) in the thrombus from histological 
analysis.  MPA was calculated from the mean platelet volume, MPV, for the specific 
blood sample provided the assumption that platelets were spherical.  For this sample, the 
MPA was 5.31 × 10-6 mm2 per platelet with a platelet diameter of 2.6 µm which was 
typical.  The distribution of platelets was assumed to be homogeneous and uniform 





  Figure 92A     Figure 92B 
Figure 92.  The thrombus in this experiment tore in half during processing.  Each half 
has been shown in Figure 92A and 92B stained with Carstairs which highlighted platelets 
in blue, fibrin in pink, WBCs in purple, and RBCs in red.  The orientation of the 
thrombus was unknown. 
 
 The relative proportion of platelets, fibrin, WBCs, and RBCs was acquired from 
histological composition analysis of Figure 92A and was 96%, 2%, 2%, and 0%, 
respectively.  Of course, fibrin overlapped on platelets and WBCs.  Hence, the proportion 
of platelets, fp, in the thrombus was 0.96.  Using Equation 17, the number of platelets in 
contact with the collagen surface was estimated as 280,000 platelets. 
 Assuming that the force was distributed only by the platelets the adhesive strength 
per platelet was approximately 32 nN, or 30 nN to one significant figure.  There may 
have been many platelet glycoproteins that were responsible for this adhesion strength.   
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 One important collagen receptor on platelets is GPIa/IIa which has approximately 
1000-2000 copies per platelet [26-28, 70].  If this was the only receptor-ligand pair 
responsible and half of the copies were in contact with collagen, the adhesive strength of 
each GPIa/IIa bond would be 30-60 pN.  This was on the right order of adhesion strength 
in comparison to the adhesion strength between platelet GPIbα and vWF which was 
determined with optical tweezers to be approximately 11 pN and in flow to be in the 
range of 36-217 pN  [56-58]. 
 
2. Platelet Attachment Strength based on Shear Rate 
 The force necessary for attachment was estimated as the viscous force on the 
surface area between the occlusive thrombus and the stenosis throat.  The attachment 
force, F, was estimated by Equation 18. 
 
     SAF ×= τ     Equation 18 
 
where the attachment force was the product of the shear stress in the throat, τ, and the 
surface area, SA, calculated as in the first method.  The surface area was calculated as in 
the first method to be 1.54 mm2.  Shear stress was calculated to be 161 Pa (1610 
dyn/cm2) using Equation 6 in Chapter III assuming Poiseuille flow.  The initial shear rate 
in experiment 12.1.2.33 was 42,200/s based on the average flow rate of 7.4 ± 0.9 mL/min 
and throat diameter of 0.310 mm.  The average flow rate was calculated for the first 4 
minutes and 15 seconds while the upstream pressure was constant at 20 mmHg.  The 
force on the surface was then estimated to be 2.5 mN by Equation 16 above.   
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 Distributed among 280,000 platelets, the force per platelet for attachment was 
estimated as 0.89 nN.  This was approximately a thirty-sixth of the estimated detachment 
strength calculated above.    
 The number of variables in the average value of adhesive strength per platelet is 
many and accounting for them would require detailed knowledge of the surface 
interactions at the periphery of the thrombus.  Some of the factors in adhesion strength of 
platelets include the initial shear stress at adhesion, conformational changes and density 
of platelet glycoproteins, kinetic rates, surface chemistry, the time between adhesion and 
detachment, and platelet density and morphology among others.  The work presented has 
provided an estimate of the adhesive strength of platelets in the range between the 
attachment and detachment strength and this may be used as an order of magnitude 
approximation. 
 In many studies, platelet adhesion strength has been interpreted as the percent 
surface coverage under varied shear rate which has demonstrated that platelets detach 
under high shear flow [50, 51, 54, 55].  Kuwahara et. al. determined that adhesive 
strength of spread platelets (>2.5 µm) was much greater than non-spread platelets which 
had a reversible binding.  Kumar found that ~50% of platelets detached when increasing 
shear stress from 0.5 to 32 dynes/cm2  [55].  In this work, the platelet adhesion strength 
has been interpreted as the strength necessary to form and detach a thrombus which 
completely occluded the vessel. 
 At what depth in the thrombus did thrombus removal occur?  This is an important 
question in deciphering the weakest receptor-ligand interaction that would be responsible 
for the detachment.  Based on images of the throat surface taken after the removal 
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experiment, it is evident that a 1-10 µm layer of thrombus existed on the walls of the 
throat.  Therefore it may be that the cleavage occurred between both platelet-platelet 
bonds and between platelet-collagen bonds.  Also there is the contribution of vWF and 
fibrin as mediators in adhesion which are present throughout the thrombus especially in 
locations with platelets.  The study of these interactions involves many variables and is 
outside the scope of this work.  The order of magnitude approximations of adhesion 
strength per platelet and per glycoprotein have been estimated and have been shown to be 
consistent with studies on that scale.  
 The force required for detachment of the thrombus is clinically significant 
because it may be used to modulate thrombolectomy forces and in cases where catheters 
are guided to the thrombus and the operator needs to know how much force to apply. 
 
Fibrin Tail Propagation 
 In non-anticoagulated ex vivo studies, fibrin tails have also been observed in 
arterial stenotic flow, but under different shear forces.  In Markou’s study, fibrin tails 
were observed at lower shear 265/s and 630/s (in the 4mm and 3mm straight tubes) and 
not in higher shear experiments or stenotic experiments [42].  The Reynolds number in 
those experiments was 130 which is the same as this work presented and is 
physiologically relevant.  In Cadroy expansion chamber, fibrin tails embolized more 
rapidly under increased shear rate and therefore were identified as a low shear 
phenomena [71].  In contrast, the Barstad et. al. study observed fibrin tail downstream to 
the collagen-attached platelet thrombus that was regularly observed for high-shear 
stenoses (10,500/s and 32,000/s) [44].  The Reynolds number in those experiments was 
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20 and therefore the tail may have formed because of the low flow conditions.  The 
models and the existence of propagating fibrin tails have been compared in Table 9 
below. 
 
Table 9.  Comparison of Fibrin Tail Observation.  Literature sources: Dichek et al. [72],  
Cadroy et al. [71, 73], Markou et al. [42], and Barstad et al. [44]. 
Study Shear Rate (1/s) Existence of Tail Reynolds # 
Dichek et al. 106 Yes 60 
Cadroy et al. 0-100 Yes 40 
Markou et al. 265 Yes 160 
Markou et al. 630 Yes 240 
Cadroy et al. 0-780 Yes 190-280 
Markou et al. 2120 Not Measured 320 
Barstad et al. 100-2600 Not Measured 20 
Markou et al. 0-5000 Not Measured 160 
Barstad et al. 17-10,500 Yes 20 
Markou et al. 0-20,000 Not Measured 160 
Barstad et al. 12-32,000 Yes 20 
Flannery 40,900 Yes 136 
 
 In the experiments in this work, thrombus propagation at high shear was found in 
at least two experiments and in one of them a long thin fibrin tail was identified.  The 
conditions that led to the formation of this tail may be conjectured from the images taken 
during thrombus formation.  The single experiment that had a propagating fibrin tail 
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distal to an occluding thrombus and a RBC packet was at very high shear rates of 
40,900/s initially and a Reynolds number of 136 in the throat.  The occluding thrombus 
slowly migrated into the throat and left a narrow channel on the order of 10-50 µm patent 
on one side of the thrombus.  This narrow channel persisted for a minute or so and may 
have produced the fibrin tail in the distal area of high residence.  Given the length and 
width of 14.2 mm and 0.8 mm, respectively, and an initial shear rate of 42,200/s, the 
force on the tail was approximately 1.8 mN. 
 The role of fibrinogen in platelet aggregation has been recognized for over 35 
years.  Propagation of fibrin has been identified in ‘flow niches’ at the separation region 
and the fiber orientation was associated with diverging streamlines at this site [74].  In 
this flow system, flow likely separated in all of the stenoses because they had Reynolds 
number greater than 10 and many had an angle of divergence from the throat of the 
stenosis to the diverging section that was greater than 7°, which is accepted to be the 
critical angle.  The separation of flow may limit the flow although this is common in 
most coronary arteries simply because of the low Reynolds number threshold. 
 The propagation of thrombus distal to the lesion is dysfunctional hemostasis.  It is 
an event typically associated with thrombosis that applies to venous thrombi, pulmonary 
embolism, and arterial atherothrombosis.  This last application has been elucidated in this 
research although further sampling is necessary to make a more firm conclusion.  In this 
experiment the vessel occluded at the throat and not at a point on the propagating 








The following have been demonstrated by this work: 
• The in vitro experiments of flowing whole porcine blood demonstrated total 
occlusion in the presence of platelets, collagen, fibrin, vWF and high shear stress 
• Complete occlusions occurred in about 25% of the cases with severe stenoses 
• The rate of platelet deposition was between 1.1 and 3.6 million platelets/cm2/s and 
it increased with shear rates between 10,000 s-1 and 40,000 s-1  
• Propagating fibrin tails formed occasionally under high shear stress when 
thrombosis led to total occlusion 
• Thrombus adhesion strength was between 0.25 and 9 mN 
• Thrombus removal from the throat of the stenosis was measured with a force of 
detachment being at the high end of about 9 mN 
 
Future Work 
 This model can visualize thrombus formation in stenotic flow with high resolution 
in whole blood.  The morphological change of platelet aggregates after adhesion is not 
well understood and the study of aggregate development and changes in platelet packing 
may be possible with this gain of resolution.  A direct marker such as fluorescently 
labeled platelets may be used to quantify the number of platelets in the throat region and 
to extract the density of the aggregate from the light intensity measured. 
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 This model has shown that platelet adhesion strength can be determined from 
thrombus removal.  It could be used to determine the effect of different initial shear rates 
on platelet adhesion strength.  In order to use this model to detect platelet strength it is 
important to directly measure thrombus development with a direct marker such as 
fluorescently labeled platelets which may be possible in a scaled down version of this 
model.  When this model is scaled down, the occurrence of embolus will likely be 
frustrating, therefore a new blood source or modification of the anticoagulant dosage is 
recommended.  This model could easily be adapted into an ex vivo shunt and would be 
most clinically relevant with human non-anticoagulated blood.  At a smaller scale on the 
order of ~100 µm, less blood volume would be required. 
 Although only evident in one thrombus formation video, the thrombus location 
appeared to migrate in the 96% stenosis video.  This may be of interest because the 
thrombus formed initially in the approximate location of peak shear rate.  And over 6 
minutes, the thrombus appeared to migrate into the throat of the stenosis leading 
ultimately to complete occlusion.  The movement and tethering of thrombus may be 
studied further using this model by collecting a greater number of images during 
thrombus formation. 
 A number of variations of this model may be made to be more physiologically 
relevant.  The effects of pulsatile flow on the formation of platelet dense regions may be 
studied by adding a pulsatile pump.  An addition of an emboli detector from light 
scattering may be used to study the rate of embolization from the thrombogenic surface.  
Blood flow patterns that are affected by thrombus development may also be studied.  
This glass model in combination with fluorescence microscopy may be used to study the 
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affect of focal thrombus which has occurred in concentric striations in this model and the 
possible vortices and changes in the recirculation region that may arise.   
 One of the most clinically relevant questions in SCD is how total thrombotic 
occlusion occurs in moderate (55% by diameter) or non-stenotic arteries.  This model 
may be used to address thrombus formation in non-stenotic flows with a high volume of 
blood over longer exposure times.  From each porcine sample, a harvesting of 5 liters of 
blood may be possible. 
 The event of occlusive thrombus formation may be altered by applying therapies 
such as pharmacological agents or by using a blood source deficient in key mediators 



























% Thrombus Formation Images used for Platelet Deposition Analysis 
% Method 2 
% Both codes in Method 1 and Method 2 yield the same number of pixels over the threshold 
% Experiment 12.15.9 





% Images to be analyzed includes the mask and appropriate succeeding images 
filename={'0015.tif','0030.tif','0045.tif','0100.tif', '0115.tif', '0130.tif', '0145.tif', '0200.tif', '0215.tif', 
'0230.tif', '0245.tif', '0300.tif', '0315.tif', '0330.tif', '0345.tif', '0400.tif', '0415.tif', '0430.tif', '0445.tif', 
'0500.tif', '0515.tif', '0530.tif', '0545.tif', '0600.tif', '0615.tif', '0630.tif', '0645.tif', '0700.tif', '0715.tif', 
'0730.tif', '0745.tif', '0800.tif', '0815.tif', '0830.tif', '0845.tif', '0900.tif', '0915.tif', '0930.tif', '0945.tif', 
'1000.tif', '1015.tif', '1030.tif', '1045.tif', '1100.tif', '1115.tif', '1130.tif', '1145.tif', '1200.tif', '1215.tif', 
'1230.tif', '1245.tif', '1300.tif', '1315.tif', '1330.tif', '1345.tif', '1400.tif', '1415.tif', '1430.tif', '1445.tif', 
'1500.tif', '1515.tif', '1530.tif', '1545.tif', '1600.tif', '1615.tif', '1630.tif', '1645.tif', '1700.tif', '1715.tif', 
'1730.tif', '1745.tif', '1800.tif', '1815.tif', '1830.tif', '1845.tif', '1900.tif', '1915.tif', '1930.tif', '1945.tif', 
'2000.tif'}; 
 
% Create mask 'c' from first image, designated '0015.tif' 
a = imread('0015.tif'); 
b = im2bw( a , 254/255); 
c = b*(-1)+1; 








% apply mask 
a = imread(name); 
d = double(a).*double(c); 
 
% convert to black and white 
% white pixels are defined by Otsu's method using GRAYTHRESH 
LEVEL = GRAYTHRESH(a); 








    for q=1:n 
        if BW(p,q)==1 
            counter=counter+1; 
        end 














% Thrombus Formation Images used for Platelet Deposition Analysis 
% Method 1 
% Both codes in Method 1 and Method 2 yield the same number of pixels over the threshold 
% Experiment 12.15.9 





% Create a list of the images in an array 
filename={'0015.tif','0030.tif','0045.tif','0100.tif', '0115.tif', '0130.tif', '0145.tif', '0200.tif', '0215.tif', 
'0230.tif', '0245.tif', '0300.tif', '0315.tif', '0330.tif', '0345.tif', '0400.tif', '0415.tif', '0430.tif', '0445.tif', 
'0500.tif', '0515.tif', '0530.tif', '0545.tif', '0600.tif', '0615.tif', '0630.tif', '0645.tif', '0700.tif', '0715.tif', 
'0730.tif', '0745.tif', '0800.tif', '0815.tif', '0830.tif', '0845.tif', '0900.tif', '0915.tif', '0930.tif', '0945.tif', 
'1000.tif', '1015.tif', '1030.tif', '1045.tif', '1100.tif', '1115.tif', '1130.tif', '1145.tif', '1200.tif', '1215.tif', 
'1230.tif', '1245.tif', '1300.tif', '1315.tif', '1330.tif', '1345.tif', '1400.tif', '1415.tif', '1430.tif', '1445.tif', 
'1500.tif', '1515.tif', '1530.tif', '1545.tif', '1600.tif', '1615.tif', '1630.tif', '1645.tif', '1700.tif', '1715.tif', 








% apply mask 
j=imread(name); 
 
% convert to black and white 
% white pixels are defined by Otsu's method using GRAYTHRESH 
LEVEL=GRAYTHRESH(j); 








    for q=1:n 
        if BW(p,q)==1 
            counter=counter+1; 
        end 

























































Matlab code used for Histological Composition Code 





% Area Proportion of Each Species 
% For each species, simply replace the title 'platelets' with the name of 
% the image 
% Conor Flannery, March 8, 2005 
 
filename=[ 'platelets' ]; 
j=imread([filename '.tif']); 
% G = rgb2gray(j); 
 
% The image is already BW and binary, but go ahead and rename it anyway 
% Images were converted to BW by ImagePro software which 
% could convert the shade of interest to white and change the background to black 
 








    for b=1:n 
        if BW(a,b)==1 
            counter=counter+1; 
        end 
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